hg_73235.1

Basic information about the TSS

---

TSS ID: hg_73235.1 Species: human Chr: chr6		Start: 34392317 End: 34392343 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: KJ893244 BT019984 BT019985 DQ893118 DQ896391 AB463951 Distance: -19 GeneID: 11165 HGNC/MGI_ID: HGNC:8050 UniProt_ID:

Gene_name: nudix hydrolase 3 Gene_symbol: NUDT3 Gene_synonyms: DIPP Gene_source: HGNC:8050

TATA-Box annotation

---

Distance to TSS:	350
Nearest PromoterID:	NM_006703
Entrez ID:	11165
Nearest Unigene:	Hs.188882
Nearest Refseq:	NM_006703
Nearest Ensembl:	ENSG00000272325
Gene Name:	nudix hydrolase 3
Gene Alias:	DIPP
Gene Description:	nudix hydrolase 3
Gene Type:	protein-coding
CpG%:	0.12
GC%:	0.716418
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NUDT3 p2@NUDT3 p3@NUDT3 p4@NUDT3 p5@NUDT3 p6@NUDT3 p7@NUDT3 p8@NUDT3 p9@NUDT3
Sample		p1@NUDT3	p2@NUDT3	p3@NUDT3	p4@NUDT3	p5@NUDT3	p6@NUDT3	p7@NUDT3	p8@NUDT3	p9@NUDT3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	25.13	3.51	0.97	3.70	0.97	2.53	0.19	0.00	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	33.79	8.30	0.40	4.25	0.40	2.43	0.20	0.20	2.63
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	27.20	6.17	0.77	3.28	0.19	1.54	0.00	0.00	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	19.34	5.41	0.21	2.29	0.42	0.83	0.00	0.00	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	27.90	6.52	0.90	3.82	0.22	0.45	0.22	0.22	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	20.35	3.68	0.00	3.49	0.78	2.52	0.19	0.00	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	22.66	6.54	0.00	3.70	0.87	3.49	0.22	0.00	2.83
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	24.22	4.60	0.73	2.18	0.97	1.45	0.00	0.00	2.18
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.51	3.85	0.21	2.99	0.43	2.35	0.21	0.00	1.50
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	27.82	6.96	1.16	2.32	1.74	1.74	0.00	0.58	8.11
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	21.83	3.64	0.40	1.62	0.40	2.83	0.00	0.81	5.26
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	20.33	4.07	0.41	1.63	0.81	1.63	0.00	0.00	8.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	22.08	1.13	0.16	0.00	0.16	0.48	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	21.65	0.75	0.15	0.00	0.15	1.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	18.44	0.44	0.00	0.00	0.22	1.54	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	22.38	2.01	0.25	0.00	0.00	0.25	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	17.04	1.09	0.22	0.00	0.00	1.09	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	18.14	1.27	0.00	0.00	0.00	1.27	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	21.33	0.53	1.07	0.00	0.00	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	19.86	1.05	0.30	0.15	0.15	1.20	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	21.92	1.74	0.13	0.00	0.13	1.07	0.00	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	20.20	1.04	0.00	0.00	0.00	1.38	0.00	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	18.87	1.81	0.26	0.00	0.13	0.90	0.00	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	17.96	0.97	0.24	0.00	0.00	0.49	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.12	1.03	0.00	0.00	0.00	2.06	0.00	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	23.42	0.32	0.00	0.00	0.00	2.22	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.33	1.10	0.00	0.00	0.55	1.10	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.28	1.89	0.00	0.00	0.24	1.89	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	17.77	0.65	0.00	0.16	0.16	0.81	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.82	0.72	0.00	0.00	0.00	1.09	0.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.42	1.26	0.00	0.21	0.21	1.05	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	18.37	1.76	0.00	0.00	0.39	0.39	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	16.04	1.06	0.21	0.00	0.00	1.06	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	17.32	1.65	0.00	0.00	0.33	1.48	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	19.45	1.68	0.19	0.00	0.00	1.31	0.00	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	19.35	1.34	0.38	0.00	0.19	0.77	0.19	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	18.39	1.64	0.41	0.00	0.00	0.61	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.48	1.01	0.00	0.00	0.00	0.81	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	19.45	1.35	0.00	0.00	0.54	1.08	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	15.12	2.40	0.24	0.00	0.00	1.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	15.06	1.41	0.00	0.00	0.00	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	16.25	1.46	0.00	0.15	0.29	0.73	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.76	1.48	0.00	0.00	0.00	0.63	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.08	1.40	0.00	0.00	0.17	1.22	0.17	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	17.87	1.20	0.00	0.00	0.00	1.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	17.22	2.33	0.23	0.23	0.00	0.93	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.71	2.16	0.00	0.00	0.00	0.72	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	16.09	2.98	0.00	0.00	0.30	0.30	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	17.00	1.20	0.00	0.00	0.48	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	13.75	0.81	0.00	0.20	0.20	1.01	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	17.63	1.84	0.00	0.00	0.41	1.43	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	16.23	2.00	0.00	0.00	0.00	0.00	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	13.99	0.00	0.00	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	10.29	0.71	0.35	0.00	0.00	1.06	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.28	0.33	0.33	0.00	0.33	1.66	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.07	2.52	0.84	0.00	0.84	5.03	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.32	2.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.02	0.97	0.32	0.00	0.00	0.65	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.24	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.52	1.26	0.00	0.00	0.00	0.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	10.58	1.41	0.00	0.00	0.00	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.73	1.12	0.00	0.00	0.00	1.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	2.39	0.00	0.00	0.00	1.59	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	11.21	2.72	0.00	0.00	0.34	1.02	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	9.10	2.60	0.00	0.00	0.00	0.65	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.52	1.77	0.00	0.00	0.35	1.42	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	0.00	0.00	0.00	0.00	48.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	23.69	0.00	0.00	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.11	0.98	0.98	0.00	0.00	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	10.91	2.48	0.00	0.00	0.00	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	11.26	0.47	0.00	0.00	0.00	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	17.88	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.99	0.62	0.00	0.00	0.00	0.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	10.09	1.53	0.00	0.00	0.00	0.92	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	25.34	2.38	0.32	0.48	0.32	1.58	0.00	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	22.94	3.85	0.16	0.32	0.32	4.01	0.00	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	19.85	4.20	0.25	0.13	0.25	2.67	0.00	0.25	0.13
Adipocyte - omental, donor2	11474-119C7	11.21	2.99	0.00	0.00	0.00	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	12.39	1.34	0.00	0.33	0.00	1.67	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	13.40	1.28	0.00	0.00	0.00	1.91	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	0.00	0.00	0.00	0.00	1.10	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	26.19	4.97	0.45	0.45	0.00	2.71	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	26.41	1.22	0.35	0.17	0.00	0.52	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	39.90	2.54	0.20	0.00	0.00	0.98	0.00	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	38.86	2.06	0.26	0.00	0.51	2.57	0.00	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	44.32	1.67	0.00	0.00	0.00	1.95	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	51.73	4.11	0.00	0.00	0.00	3.53	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	42.23	2.01	0.48	0.32	0.24	2.25	0.08	0.08	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	42.93	1.94	0.65	0.65	0.65	2.58	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	25.06	2.13	1.07	0.00	0.00	1.60	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	40.06	2.78	0.00	0.00	0.00	3.90	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	25.79	1.66	0.00	0.42	0.00	4.16	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	33.15	1.26	0.25	0.25	0.00	1.51	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	33.71	2.95	0.98	0.00	0.33	1.64	0.00	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	34.41	1.83	0.61	0.30	0.30	3.04	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	24.97	4.20	0.22	0.66	0.88	2.21	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	11.12	1.79	0.00	0.36	0.00	2.15	0.00	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	20.37	0.00	0.00	0.00	0.00	2.40	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	24.65	1.08	0.00	0.00	0.54	1.62	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	16.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	23.01	3.90	0.21	0.00	0.00	2.05	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	28.03	1.37	0.46	0.00	0.00	2.06	0.00	0.34	0.00
Anulus Pulposus Cell, donor2	11463-119B5	16.16	0.73	0.24	0.24	0.00	1.47	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.83	2.25	0.00	0.45	0.45	3.15	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	18.67	1.74	0.43	0.00	0.00	4.78	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	0.00	0.00	0.00	0.00	6.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	16.14	2.99	0.30	0.00	0.60	1.49	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	18.97	1.26	0.00	0.00	0.00	2.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	1.32	0.00	0.00	0.00	1.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	16.89	0.32	1.30	0.32	0.32	2.60	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.99	0.49	0.49	0.00	0.49	2.91	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.66	1.78	0.59	0.00	0.59	1.78	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.21	2.26	0.38	0.00	0.38	5.27	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	17.42	1.45	0.73	0.00	0.00	1.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	1.25	1.25	0.00	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	15.81	3.62	0.33	0.00	0.00	1.98	0.00	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	1.36	0.00	0.00	1.36	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.95	1.06	0.15	0.00	0.15	1.81	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	18.22	3.21	0.00	0.00	0.54	3.75	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	19.46	3.59	0.19	0.00	0.76	2.27	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.64	1.07	0.00	0.00	0.00	3.47	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	22.44	3.90	0.00	0.00	0.00	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	16.42	2.32	0.00	0.17	0.17	2.65	0.00	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	2.40	0.00	0.00	0.00	2.40	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	7.08	0.00	0.00	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.89	0.86	0.00	0.34	0.17	2.92	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	0.00	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	13.59	1.46	0.49	0.49	0.00	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.04	3.04	0.38	0.00	1.14	3.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	0.00	0.00	0.00	2.42	2.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	18.24	1.14	0.00	0.57	0.00	3.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	17.53	0.86	0.64	0.43	0.21	2.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.36	2.32	0.26	0.77	0.52	2.06	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.61	2.35	0.00	0.00	0.00	1.88	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.79	1.93	0.32	0.00	0.64	2.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	0.71	0.71	0.00	0.00	3.57	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	21.64	0.00	0.00	0.00	0.00	4.68	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	15.05	1.51	0.00	0.30	1.20	1.81	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	15.44	3.56	0.00	0.00	0.00	3.56	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	15.77	2.54	0.00	0.00	0.00	4.07	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.01	2.29	0.00	0.00	1.27	2.04	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	3.18	0.00	0.00	0.00	2.54	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	19.85	0.43	0.43	0.00	0.43	3.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	14.82	1.69	0.21	0.00	0.21	2.75	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.08	2.32	0.00	0.00	0.58	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	1.89	0.94	0.94	0.00	4.72	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	14.58	1.86	0.17	0.17	0.00	2.03	0.00	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	0.00	0.00	2.32	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.37	1.29	0.21	0.21	0.00	3.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.63	0.00	0.00	0.00	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	17.50	2.19	0.00	0.73	0.00	3.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.10	2.53	0.00	0.69	0.00	3.22	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	0.00	0.00	0.00	0.00	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.19	1.53	0.00	0.00	0.51	2.03	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	15.48	1.24	0.00	0.41	0.41	2.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.24	1.22	0.31	0.31	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	20.08	1.43	0.00	0.48	0.96	2.39	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	17.07	0.89	0.22	0.22	0.44	3.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	3.05	0.00	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	14.40	3.32	0.00	0.00	0.55	3.88	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.09	2.38	0.26	0.00	0.00	3.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.17	1.45	0.00	0.36	0.00	2.91	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	30.70	3.81	0.00	0.25	0.00	6.39	0.00	0.12	0.25
Astrocyte - cerebellum, donor2	11580-120F5	27.04	2.91	0.00	0.00	0.00	5.13	0.17	0.51	0.00
Astrocyte - cerebellum, donor3	11661-122F5	31.25	0.42	0.00	0.00	0.21	4.40	0.00	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	69.02	6.62	1.39	0.35	0.70	9.06	0.00	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	52.90	4.37	0.49	0.00	0.49	11.32	0.32	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	68.76	5.07	0.45	0.60	0.60	7.01	0.30	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	58.03	4.36	0.80	0.92	0.34	7.34	0.00	0.57	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	53.12	5.76	1.25	0.38	0.50	8.02	0.00	0.25	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	51.32	5.01	1.14	0.80	0.11	7.85	0.11	0.34	0.34
Basophils, donor1	12241-129G9	49.69	5.49	0.26	0.26	0.52	2.09	0.00	0.00	0.52
Basophils, donor2	12242-129H1	55.92	5.41	0.72	0.00	0.00	1.80	0.00	0.00	0.36
Basophils, donor3	12243-129H2	48.80	3.67	0.73	0.29	0.29	2.06	0.29	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	22.21	1.08	0.22	0.00	0.00	1.51	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	17.83	1.37	0.00	0.46	0.46	0.91	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	0.00	0.00	0.00	0.00	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.69	0.63	0.00	0.00	0.00	3.14	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	23.91	1.25	0.00	0.00	0.00	1.66	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	14.05	1.84	0.46	0.00	0.23	1.15	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	30.41	0.90	0.36	0.18	0.18	1.98	0.00	0.18	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	57.20	7.83	1.75	0.31	1.55	8.97	0.00	0.62	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	73.83	3.96	1.16	0.23	1.16	6.99	0.47	0.23	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	97.21	5.44	0.32	0.00	0.64	5.12	0.00	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	206.84	0.00	10.34	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	54.66	4.51	0.00	0.56	2.25	1.69	0.56	0.00	1.69
CD14+ Monocytes, donor2	11305-117B9	56.79	5.57	0.19	0.19	0.56	1.48	0.19	0.00	1.86
CD14+ Monocytes, donor3	11381-118B4	57.08	5.05	0.00	0.22	1.10	1.76	0.44	0.00	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	66.52	7.36	1.42	0.28	1.13	9.06	0.28	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	45.87	1.90	0.00	0.38	0.00	3.41	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	69.36	5.92	1.64	0.00	0.33	4.60	0.00	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	59.41	11.56	0.43	0.29	2.60	4.19	0.58	0.00	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	54.62	6.34	0.00	0.60	2.11	4.83	0.60	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	72.73	14.69	0.47	0.71	1.90	5.69	0.00	0.00	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	33.81	6.86	0.00	0.17	1.34	2.18	0.17	0.17	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	30.36	7.18	0.00	0.55	1.10	1.93	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	36.45	6.94	0.00	0.25	0.50	1.49	0.00	0.00	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	25.45	3.52	0.00	0.00	0.20	1.96	0.00	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	34.01	5.52	0.18	0.18	0.36	2.31	0.18	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	38.74	4.35	0.44	0.44	0.65	1.52	0.22	0.22	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	24.35	3.04	0.00	0.23	0.23	0.47	0.00	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	40.13	1.06	0.53	0.53	0.00	2.64	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	31.06	6.66	0.00	0.00	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	43.14	5.65	0.15	0.00	0.59	3.42	0.45	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	36.32	6.19	0.00	0.40	0.80	1.80	0.00	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	40.81	8.54	0.42	0.21	1.25	2.91	0.42	0.00	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	31.57	8.01	0.00	0.23	0.92	1.60	0.46	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	38.23	9.27	0.23	0.23	0.00	1.81	0.00	0.23	1.36
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	29.68	6.11	0.87	0.00	0.44	3.93	0.44	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	43.04	9.68	0.00	0.00	1.08	2.42	0.54	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	52.69	8.20	0.00	0.00	0.87	4.36	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	63.12	13.47	0.00	0.00	2.10	2.10	0.84	0.00	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	27.74	7.35	0.37	0.55	0.18	0.73	0.37	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	27.48	10.22	0.35	1.06	0.70	1.06	0.00	0.00	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	36.41	12.28	0.44	0.88	1.75	1.32	0.00	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	30.52	1.22	0.00	0.35	0.70	2.09	0.17	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	32.34	3.35	0.00	1.49	0.37	1.86	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	38.15	3.45	0.43	0.22	0.65	2.16	0.00	0.22	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	27.85	6.14	0.00	0.00	0.82	1.64	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	27.82	6.72	0.00	0.23	0.23	2.55	0.00	0.00	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	29.23	8.12	0.00	0.23	1.16	1.16	0.46	0.00	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	55.80	2.83	0.44	0.22	1.09	4.58	0.22	0.00	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	62.37	4.39	0.23	0.00	1.39	3.00	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	63.04	4.77	0.87	0.00	0.43	1.52	0.00	0.00	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	79.42	4.67	0.93	0.16	0.78	4.98	0.31	0.00	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	71.08	3.84	0.52	0.17	0.52	3.49	0.00	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	103.68	5.13	0.67	0.45	1.34	5.57	0.22	0.00	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	81.40	4.34	0.77	0.51	0.77	2.55	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	59.50	5.49	0.00	0.66	1.54	3.29	0.00	0.00	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	73.06	4.42	0.21	0.42	1.26	2.32	0.21	0.00	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	79.26	0.00	0.00	0.00	0.00	6.10	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	73.90	3.39	2.03	0.00	0.00	7.46	0.68	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	71.46	6.21	1.04	1.04	1.04	8.28	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	72.49	6.93	0.00	0.00	0.00	3.20	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	82.02	2.68	0.54	0.54	0.54	6.43	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	73.00	4.21	0.70	0.70	0.00	11.93	0.70	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	70.59	3.92	0.00	0.78	1.57	5.49	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	100.19	3.95	0.00	0.00	0.00	2.64	1.32	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	77.26	2.47	0.82	0.00	1.64	4.93	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	63.11	3.63	0.73	0.00	0.00	2.90	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	53.51	2.52	0.50	0.00	1.01	3.53	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	25.46	1.21	0.40	0.00	0.00	1.62	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	21.57	1.60	0.00	0.00	0.00	1.20	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	66.27	3.01	1.00	0.00	0.00	7.03	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	39.33	5.62	0.00	0.00	0.00	3.93	0.00	1.12	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	72.14	4.88	0.00	0.00	1.50	7.14	0.00	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	81.17	4.06	1.13	0.45	0.68	6.09	0.23	0.23	0.45
CD4+ T Cells, donor1	11225-116C1	62.13	7.50	0.71	0.00	0.71	1.07	0.36	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	61.24	4.29	0.00	0.00	0.00	1.84	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	57.03	1.83	0.30	0.00	0.61	3.05	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	43.65	1.02	0.26	0.26	0.00	1.28	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	41.78	1.12	0.00	0.00	0.22	0.45	0.00	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	47.72	1.44	0.00	0.57	0.00	0.86	0.00	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	59.74	2.84	0.00	0.00	0.47	1.90	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	49.16	4.21	0.70	0.00	0.70	1.40	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	75.81	0.00	3.30	3.30	0.00	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	34.68	1.59	0.58	0.00	0.43	1.01	0.00	0.00	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	36.60	1.02	0.34	0.00	0.00	0.85	0.00	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	30.63	0.48	0.48	0.00	0.00	1.45	0.00	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	41.24	1.34	0.45	0.00	0.00	1.34	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	41.93	2.10	0.35	0.00	0.00	1.40	0.00	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	43.56	1.32	0.00	0.00	0.00	0.88	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	36.68	0.84	0.42	0.00	0.00	1.26	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	31.58	0.42	0.21	0.62	0.21	1.45	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	26.73	0.67	0.00	0.00	0.67	2.67	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	49.76	2.45	0.82	0.00	0.27	2.45	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	68.60	2.14	0.54	0.54	0.00	2.68	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	52.00	0.00	0.00	0.00	0.00	3.59	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	42.09	1.48	0.56	0.00	0.00	1.11	0.00	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	34.01	1.52	0.22	0.00	0.00	0.65	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	34.25	1.05	0.42	0.00	0.21	0.84	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	52.08	2.53	0.00	0.00	0.00	2.53	0.00	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	49.82	2.60	0.00	0.00	0.43	1.30	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	39.66	1.74	0.00	0.00	0.00	0.87	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	60.37	1.48	0.99	0.00	0.00	1.98	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	50.78	4.62	0.00	0.00	0.92	2.77	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	58.62	0.00	0.00	0.00	0.00	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	50.12	3.05	0.00	0.28	0.00	1.66	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	50.55	2.94	0.25	0.25	0.49	1.47	0.00	0.49	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	56.98	3.08	1.54	0.00	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	59.81	3.58	0.72	0.00	0.36	4.30	0.00	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	62.32	0.00	0.00	0.00	0.00	2.77	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	55.66	7.53	0.33	0.33	0.65	1.31	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	49.93	5.63	0.00	0.00	0.00	1.50	0.38	0.00	0.75
CD8+ T Cells, donor3	11383-118B6	61.10	5.55	0.50	0.25	0.50	2.27	0.00	0.00	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	17.43	2.98	0.00	0.23	0.46	1.38	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	14.86	1.20	0.24	0.00	0.24	1.44	0.00	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.69	1.64	0.27	0.55	0.27	1.09	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	9.31	1.80	0.00	0.90	0.30	1.20	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	15.12	2.40	0.00	0.48	0.24	1.44	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	18.19	2.73	0.23	0.23	0.00	1.36	0.23	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	16.73	2.17	0.22	0.87	0.00	1.09	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.53	3.42	0.26	0.53	0.26	0.79	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	18.29	0.94	0.23	0.47	0.00	1.88	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	18.72	1.81	0.00	0.30	0.30	0.91	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.36	1.74	0.00	0.29	0.00	0.87	0.29	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	19.45	2.13	0.27	0.00	0.00	2.40	0.00	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.07	3.94	0.00	0.00	0.88	1.75	0.00	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.47	4.10	0.00	0.00	0.00	1.37	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.95	2.24	0.00	0.00	0.00	1.49	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	17.65	2.88	0.72	0.72	0.36	0.72	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	13.24	3.45	0.58	0.00	0.29	1.44	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	14.14	3.06	0.00	0.00	0.00	2.59	0.00	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	15.85	2.85	0.32	0.00	0.95	1.90	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.69	1.85	0.00	1.23	0.31	1.85	0.00	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	15.39	1.28	0.32	0.32	0.00	1.28	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.56	3.44	0.00	0.38	0.00	1.15	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.10	3.55	0.00	0.00	0.00	1.18	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	17.40	3.78	0.00	0.76	0.00	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	3.21	3.21	0.80	0.00	0.00	1.61	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	11.89	3.50	0.70	0.70	0.00	0.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	12.02	2.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	29.24	3.66	0.00	0.00	1.83	5.48	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	31.62	0.99	0.49	0.00	0.00	3.46	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	24.31	3.05	0.11	0.11	0.32	2.53	0.11	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	12.83	1.39	0.00	0.35	0.00	3.47	0.69	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	22.39	2.13	0.00	0.36	0.00	3.20	0.00	0.00	0.71
Chondrocyte - de diff, donor3	11410-118E6	30.49	2.39	0.46	0.23	0.23	2.50	0.00	0.11	0.00
Chondrocyte - re diff, donor2	11339-117F7	42.97	7.16	0.90	0.00	2.69	12.53	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	49.34	5.66	0.40	0.40	0.81	2.43	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	52.21	4.82	0.92	0.57	0.11	7.46	0.00	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	37.84	2.99	0.43	0.21	0.21	4.92	0.00	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	40.09	2.83	0.44	0.35	0.53	5.31	0.18	0.00	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	82.07	10.82	1.74	1.47	2.11	10.55	0.09	0.18	0.37
Corneal Epithelial Cells, donor1	11526-119I5	29.64	1.76	0.22	0.22	0.22	2.42	0.22	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	18.20	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	33.23	2.81	0.51	0.26	0.26	3.07	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	35.99	7.26	0.17	0.33	0.17	2.15	0.17	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	44.79	5.68	0.32	1.26	0.32	2.52	0.00	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	32.50	6.70	0.32	0.86	0.11	2.48	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	47.15	5.81	0.68	0.34	0.68	1.37	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	43.74	9.14	0.65	0.65	1.31	3.26	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	31.94	9.19	0.00	0.00	0.00	2.90	0.00	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	27.85	2.67	0.33	0.50	0.67	6.34	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	26.99	1.76	0.59	0.00	1.17	1.76	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	37.33	4.52	0.00	0.57	0.85	9.05	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	29.88	2.36	0.39	0.39	0.79	5.90	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	20.94	3.49	0.00	0.29	0.87	1.16	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	31.06	3.53	0.24	0.47	0.47	6.35	0.00	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	27.52	3.33	0.18	0.18	0.70	6.14	0.18	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	42.78	3.77	0.89	0.66	0.22	5.98	0.22	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	31.95	2.74	0.30	0.00	0.30	5.17	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	32.42	1.69	1.13	0.28	0.85	2.54	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	19.02	2.08	0.00	0.30	0.30	1.19	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	25.51	0.52	0.52	0.52	1.04	3.12	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	25.81	2.27	0.28	0.43	0.43	2.84	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	25.61	4.80	0.40	0.00	0.80	4.40	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	24.63	3.67	0.00	0.52	0.00	3.67	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	66.10	5.47	0.75	0.75	0.87	7.83	0.25	0.00	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	62.35	2.39	0.22	1.30	0.43	7.82	0.00	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	67.05	3.30	0.37	0.49	0.73	4.89	0.00	0.24	0.12
Endothelial Cells - Vein, donor1	11267-116G7	21.61	4.55	0.00	0.00	0.00	3.41	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	20.96	2.79	0.00	0.70	1.40	3.49	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	36.27	4.55	0.47	0.16	1.10	3.61	0.16	0.16	0.00
Eosinophils, donor1	12244-129H3	91.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	207.93	61.06	0.00	3.30	3.30	18.15	3.30	0.00	18.15
Eosinophils, donor3	12246-129H5	135.54	7.13	0.00	0.00	3.57	3.57	3.57	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	24.92	0.24	0.49	0.00	0.24	0.98	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	0.00	0.00	0.00	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	17.65	2.46	0.00	0.41	0.00	2.46	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	14.78	0.77	0.00	0.11	0.33	1.42	0.00	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	30.01	2.82	0.11	0.33	0.54	1.84	0.22	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	26.68	4.85	0.49	0.12	0.36	4.37	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	11.33	1.77	0.00	0.00	0.41	2.05	0.00	0.00	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	22.36	2.43	0.21	0.32	0.21	2.74	0.21	0.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	12.38	1.58	0.00	0.00	0.26	2.90	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	31.23	4.32	0.00	0.33	0.00	2.33	0.33	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	22.68	3.63	0.91	0.00	0.45	3.63	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	18.95	3.03	0.00	0.00	0.00	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	18.30	3.63	0.16	0.16	0.79	1.42	0.00	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	33.04	1.82	0.00	0.61	1.21	3.64	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	26.52	2.54	0.00	0.38	0.38	4.31	0.00	0.00	0.13
Fibroblast - Cardiac, donor6	11460-119B2	22.89	1.97	0.15	0.30	0.45	3.79	0.00	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	36.45	5.49	0.40	0.27	0.27	4.96	0.00	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	34.95	4.75	0.00	0.00	0.43	6.04	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	39.55	2.93	0.00	0.00	0.00	4.39	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	53.28	6.46	0.46	0.23	0.00	4.61	0.00	0.23	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	54.95	3.22	0.68	0.17	0.68	5.60	0.00	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	30.52	1.88	0.23	0.47	0.47	2.82	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	36.79	1.42	0.00	1.42	0.47	6.13	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	38.08	5.56	0.36	0.36	0.24	5.08	0.12	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	32.22	3.17	0.00	0.11	0.45	4.30	0.11	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	33.15	2.62	0.17	0.17	0.52	5.93	0.00	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	35.90	5.85	0.00	0.16	0.32	5.85	0.00	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	44.14	3.75	0.62	0.00	0.42	5.21	0.00	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	38.25	5.76	0.26	0.26	0.00	3.93	0.00	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	46.26	2.11	0.53	0.00	0.40	6.19	0.00	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	50.95	2.90	0.58	0.19	0.19	4.25	0.10	0.10	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	38.44	5.19	0.00	0.00	1.04	8.31	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	35.06	3.70	0.35	0.00	0.35	3.17	0.00	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	28.37	3.74	0.31	0.00	0.00	1.87	0.16	0.16	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	33.40	5.14	0.27	0.14	0.54	6.36	0.14	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	34.58	3.88	0.35	0.35	0.00	4.23	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	25.59	4.83	0.29	0.15	0.29	4.24	0.29	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	25.77	3.68	0.41	0.00	0.27	4.09	0.27	0.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	28.19	6.91	0.00	0.11	0.99	4.17	0.00	0.00	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	71.90	9.24	1.61	0.44	0.29	6.02	0.15	0.29	0.15
Fibroblast - Lung, donor1	11270-116H1	16.31	0.00	0.00	0.00	0.00	2.72	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	34.32	2.98	0.00	0.00	0.00	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	41.15	4.01	0.00	0.21	0.63	5.91	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	29.99	5.00	0.00	0.83	0.00	5.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	0.00	1.40	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	15.95	2.24	0.28	0.00	0.28	1.12	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	42.22	5.68	0.00	0.81	0.41	4.47	0.00	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	0.00	0.00	0.00	3.99	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	40.73	2.72	1.16	0.00	0.19	7.37	0.00	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	55.21	1.97	0.46	0.00	0.30	7.28	0.00	0.00	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	40.08	4.28	0.00	0.61	0.92	5.20	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	33.20	4.96	0.38	0.00	0.00	4.58	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.65	5.13	0.27	0.27	0.27	2.70	0.27	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	39.78	4.99	0.23	0.35	0.23	3.83	0.00	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	28.08	3.32	0.33	0.44	0.44	3.65	0.11	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	40.64	4.88	1.22	0.20	0.41	5.89	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	37.42	3.34	0.00	0.00	0.67	3.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	36.77	2.77	0.00	0.00	0.00	4.74	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	9.92	3.97	0.40	0.00	0.40	3.77	0.00	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	26.29	3.20	0.18	0.36	0.53	2.84	0.18	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	28.38	2.56	0.39	0.59	0.20	3.94	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	7.82	0.90	0.00	0.00	0.30	1.50	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	20.62	4.86	0.00	0.11	0.22	4.53	0.22	0.22	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	9.36	0.51	0.25	0.00	0.00	1.27	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	23.30	2.13	0.16	0.33	0.66	1.48	0.16	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	12.03	4.21	0.00	0.00	0.20	2.01	0.20	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	14.57	5.02	0.10	0.20	0.40	3.01	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	12.69	1.51	0.00	0.00	0.00	2.72	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	31.07	3.73	0.33	0.25	0.17	2.24	0.08	0.17	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	26.67	3.59	0.00	0.34	0.17	3.08	0.00	0.00	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	6.90	0.99	0.33	0.00	0.33	0.99	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	15.02	3.94	0.11	0.00	0.11	3.83	0.11	0.00	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	20.92	3.04	0.17	0.51	0.67	3.37	0.17	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.98	2.35	0.00	0.16	0.63	2.20	0.00	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.09	2.61	0.00	0.87	0.87	6.10	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	17.68	2.08	0.17	0.17	0.17	3.47	0.17	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	20.56	2.08	0.26	0.78	0.00	2.08	0.00	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	18.65	2.56	0.00	0.51	0.51	1.79	0.26	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	38.28	3.83	0.00	0.77	0.77	3.06	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	47.86	0.64	0.64	0.00	0.00	4.47	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	73.31	3.42	0.29	0.29	2.57	5.99	0.29	0.29	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	55.43	2.21	0.00	0.00	0.00	4.14	0.00	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	71.01	4.57	0.23	0.23	0.91	5.71	0.23	0.23	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	48.94	2.38	0.40	0.20	0.79	5.35	0.00	0.00	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	52.34	2.91	0.79	0.00	0.00	3.97	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	67.84	4.57	0.33	0.00	2.28	6.20	0.00	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	49.53	6.63	0.00	0.44	1.77	7.08	0.00	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	54.97	2.26	0.42	0.00	0.42	6.08	0.14	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	48.15	3.94	0.37	0.12	0.49	6.03	0.00	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	41.91	2.42	0.00	0.27	0.00	4.03	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	40.39	3.35	0.25	0.50	0.25	3.59	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	44.16	2.63	0.14	0.28	0.00	4.43	0.14	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	31.72	2.44	0.20	0.00	0.61	3.66	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	26.47	2.28	0.23	0.00	0.23	4.34	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	37.62	1.62	0.00	0.12	0.75	2.24	0.00	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	28.20	1.31	0.44	0.22	0.66	4.15	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	41.66	2.36	0.00	0.30	0.59	5.32	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	48.16	3.18	0.48	0.16	0.95	5.56	0.00	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	32.17	0.89	0.22	0.00	0.22	2.90	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	47.38	3.23	0.60	0.00	0.40	5.44	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	59.37	3.73	0.68	0.00	0.85	4.75	0.17	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	33.07	2.75	0.62	0.00	0.18	4.34	0.00	0.18	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.36	2.81	0.21	0.10	0.52	3.95	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.79	2.73	0.17	0.00	0.51	5.29	0.00	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	51.90	2.88	0.11	0.44	0.22	4.43	0.11	0.33	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.36	2.75	0.42	0.00	0.33	4.33	0.08	0.08	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.22	2.45	0.00	0.00	0.41	4.29	0.20	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	44.56	2.06	0.41	0.21	0.41	5.16	0.21	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	52.34	3.11	0.46	0.00	0.46	5.19	0.00	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	36.69	4.84	0.33	0.00	0.33	5.67	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	35.49	2.42	0.44	0.00	0.22	4.19	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	53.87	2.34	0.37	0.25	0.49	4.80	0.12	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	40.52	2.43	0.49	0.16	0.49	4.54	0.65	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	38.17	2.89	0.96	0.00	0.32	6.74	0.64	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	44.16	3.32	0.38	0.19	0.38	4.26	0.00	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	30.84	2.85	0.00	0.16	0.00	2.06	0.16	0.00	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	40.44	4.26	0.00	0.00	0.30	2.74	0.30	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	45.06	4.08	0.31	0.10	0.52	5.75	0.00	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	29.64	2.85	0.44	0.66	0.22	3.73	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	39.00	3.09	0.00	0.00	0.56	5.61	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	41.76	4.72	0.28	0.09	0.56	6.20	0.19	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	26.21	2.41	0.80	0.00	0.00	3.21	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	33.20	3.83	0.15	0.00	0.77	4.13	0.31	0.15	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	34.33	3.76	0.00	0.26	0.13	3.89	0.13	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	28.19	2.98	0.81	0.27	0.27	2.44	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	35.40	2.77	0.00	0.00	0.18	3.87	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	36.84	1.97	0.22	0.22	0.66	5.26	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	37.69	1.98	0.00	0.99	0.00	3.97	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	33.37	2.77	0.40	0.13	0.13	2.51	0.00	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	38.74	1.82	0.20	0.00	0.61	4.64	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	31.52	2.54	0.76	0.00	0.00	4.32	0.25	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	39.81	2.99	0.00	0.20	0.60	5.77	0.00	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	59.32	2.47	0.15	0.15	0.31	6.78	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	87.15	4.09	0.41	0.20	0.61	10.43	0.00	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	32.54	4.07	0.00	0.00	0.00	3.76	0.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	35.88	2.54	0.28	0.00	1.13	5.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	42.89	4.15	0.00	0.46	0.46	5.07	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	4.95	0.00	0.00	0.00	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	40.23	4.64	0.77	0.00	0.39	3.48	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	3.21	0.00	0.00	0.00	6.42	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	60.86	3.48	0.00	0.00	0.00	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	39.71	0.98	0.00	0.33	0.98	3.91	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	44.89	4.12	0.41	0.00	0.82	2.47	0.00	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	0.00	0.00	0.00	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	33.00	2.24	0.56	0.00	1.12	2.80	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	36.93	3.27	0.00	0.00	0.33	1.63	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	36.91	0.84	0.00	0.00	0.84	0.84	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	43.26	1.91	0.00	0.00	0.32	5.09	0.00	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	36.00	1.02	0.68	0.00	0.68	3.06	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	39.67	2.09	0.00	0.00	0.00	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	40.66	4.58	0.57	0.00	0.00	3.44	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	27.82	2.07	0.00	0.00	0.00	2.37	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	59.30	1.69	0.00	0.00	1.69	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	39.76	2.90	0.83	0.00	1.66	4.14	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	40.50	2.53	0.23	0.00	0.92	2.99	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	32.68	1.92	0.00	0.00	0.38	4.23	0.38	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	21.84	1.63	0.33	0.00	0.00	3.26	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	36.79	0.67	0.67	0.00	0.67	2.01	0.00	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	36.99	1.16	0.00	0.39	0.77	3.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	33.21	2.40	0.00	0.00	0.68	1.37	0.00	0.00	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	2.48	0.00	0.00	0.00	9.94	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	27.84	1.42	0.94	0.00	0.94	1.89	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	39.83	1.21	0.60	0.00	0.00	3.02	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	36.12	0.51	0.00	0.00	1.02	3.05	0.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	41.88	1.99	0.40	0.00	0.40	2.79	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	34.53	0.99	0.49	0.00	0.99	6.41	0.00	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	36.59	1.18	1.18	0.00	2.36	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	46.09	2.33	0.58	0.00	0.00	4.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.02	3.07	0.00	0.00	0.44	2.63	0.00	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	34.76	0.85	0.85	0.00	0.00	2.54	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	34.62	3.58	0.60	0.00	1.19	5.37	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	34.94	3.40	0.00	0.49	0.00	4.85	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	23.97	1.14	0.00	1.14	0.00	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	18.71	1.66	0.00	0.00	0.00	1.66	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	23.61	0.00	0.00	0.00	0.00	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	23.47	1.59	0.00	0.00	0.63	0.95	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	21.30	0.00	0.42	0.42	0.42	1.67	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.04	5.34	0.35	0.81	0.35	6.15	0.46	0.12	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	35.79	5.40	0.34	0.84	0.68	5.91	0.00	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	42.77	5.92	0.23	0.91	0.46	4.78	0.00	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	36.51	4.04	0.66	0.55	1.09	5.14	0.00	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	38.68	4.94	0.21	1.50	1.07	5.80	0.00	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	34.66	4.74	0.22	1.08	0.86	4.95	0.22	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	30.64	4.86	0.50	0.50	0.62	3.74	0.12	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	23.67	3.77	0.51	0.69	0.34	4.63	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	31.40	3.52	0.32	0.96	1.28	3.52	0.00	0.00	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	31.34	4.48	0.00	0.56	0.56	3.36	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	25.10	1.30	0.00	0.00	0.00	3.90	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	0.00	0.00	0.00	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	31.39	1.41	0.71	0.00	0.00	2.47	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	21.07	1.45	0.00	0.00	0.73	2.18	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	19.06	2.62	0.00	0.00	0.87	1.40	0.00	0.00	0.00
Hepatocyte, donor1	11523-119I2	58.11	4.84	0.00	0.00	0.00	6.05	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	52.79	2.15	2.15	0.00	1.08	4.31	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	64.42	1.84	1.84	0.00	0.61	2.45	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	53.52	5.22	0.00	0.00	0.65	3.26	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	22.90	0.87	0.35	0.00	0.00	1.40	0.00	0.35	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	22.23	0.55	0.41	0.00	0.00	3.16	0.00	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	6.37	0.00	3.18	0.00	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	13.35	0.00	0.00	0.00	13.35	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	37.38	2.77	1.38	0.00	0.00	5.54	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	2.50	0.00	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	51.26	10.25	0.00	0.00	0.00	5.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	4.57	0.00	4.57	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	58.48	4.87	0.00	0.00	1.62	4.87	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	36.68	8.34	1.67	0.00	0.00	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	0.00	3.63	0.00	0.00	10.89	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	46.32	9.26	0.00	2.65	2.65	6.62	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	36.59	4.43	0.00	0.00	1.11	2.22	0.00	0.00	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	0.00	0.00	0.00	0.00	5.24	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	41.57	3.78	0.63	0.63	0.63	9.45	0.00	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	47.95	9.28	1.55	1.55	4.64	6.19	1.55	0.00	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	39.41	3.88	0.00	0.00	0.00	3.88	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	24.15	12.88	1.61	0.00	0.00	3.22	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	44.00	3.26	0.81	0.00	0.81	4.89	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	26.03	4.20	0.42	0.00	0.42	4.62	0.00	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	40.99	8.04	0.00	0.80	1.61	6.43	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	34.16	3.69	0.00	0.00	0.00	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	52.40	8.02	0.94	0.94	0.94	7.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	28.12	5.44	0.00	0.00	0.00	2.72	0.00	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	58.11	6.46	0.00	0.00	2.15	7.53	0.00	1.08	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	43.20	5.08	0.00	2.54	0.00	2.54	0.00	0.00	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	36.35	3.19	1.91	0.64	1.28	3.83	0.00	0.00	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	5.47	0.00	0.00	0.00	1.82	0.00	0.00	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	37.85	2.86	0.00	0.71	0.00	2.86	0.00	0.00	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	0.00	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	41.67	4.63	0.31	1.23	0.62	4.94	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	33.36	3.51	0.00	0.00	0.00	3.51	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	0.00	3.14	0.00	0.00	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	45.90	2.09	0.00	0.00	0.00	3.48	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	8.85	0.00	4.43	2.21	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	6.48	0.00	0.00	0.00	3.24	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	58.42	4.36	1.74	0.00	0.00	2.62	0.00	0.00	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	45.00	2.25	2.25	0.00	0.00	4.50	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	0.00	0.00	3.48	0.00	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	38.40	6.40	1.07	0.00	0.00	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	30.48	1.39	1.39	1.39	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	2.85	0.00	2.85	0.00	0.00	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	37.74	0.92	1.84	0.92	0.00	3.68	0.00	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	0.00	0.00	0.00	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	39.12	1.06	0.00	0.00	0.00	3.17	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	22.52	3.02	0.24	0.24	0.24	3.35	0.00	0.00	0.08
Keratinocyte - epidermal, donor2	11349-117G8	12.30	2.34	0.00	0.59	0.00	1.17	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	37.39	1.51	0.00	0.09	0.38	2.46	0.00	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	52.90	1.36	1.48	0.00	0.34	3.41	0.00	0.11	0.00
Keratocytes, donor1	11527-119I6	49.17	3.78	0.00	0.34	1.38	3.44	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	29.30	1.17	0.00	0.00	1.17	4.69	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	39.12	1.38	0.20	0.00	0.40	2.37	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	63.74	4.40	0.00	0.00	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	29.13	1.08	0.00	0.00	0.00	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	35.52	2.88	0.46	0.12	0.00	3.92	0.12	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	22.91	2.83	0.00	0.10	0.30	4.74	0.20	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	24.78	1.30	0.00	0.00	0.36	2.02	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	17.58	1.12	0.00	0.00	0.56	1.40	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.97	2.20	0.63	0.00	0.31	2.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	27.96	0.00	0.00	0.00	0.00	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	20.17	1.89	0.63	0.00	0.00	2.21	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	21.67	2.37	0.11	0.11	0.11	2.05	0.00	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	21.75	0.41	0.41	0.00	0.82	1.64	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.66	1.01	0.00	0.00	0.00	1.77	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.58	2.25	0.14	0.14	0.28	2.25	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	17.01	0.40	0.40	0.00	0.40	1.58	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	16.48	0.97	0.00	0.00	0.19	1.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	12.78	1.11	0.19	0.00	0.19	2.04	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.53	2.09	0.00	0.00	0.35	1.74	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	20.75	2.39	0.00	0.24	0.24	1.91	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	20.05	1.51	0.00	0.27	0.69	1.79	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.17	1.54	0.00	0.62	0.31	2.16	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.28	0.31	0.00	0.00	0.00	2.18	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	20.86	1.10	0.37	0.00	0.00	2.38	0.00	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	22.38	1.65	0.33	0.00	0.00	2.30	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.89	1.76	0.00	0.00	0.29	2.34	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	18.42	1.00	0.00	0.00	0.25	1.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.52	1.94	0.00	0.48	0.00	3.39	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.12	2.42	0.27	0.00	0.00	2.96	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	24.37	2.57	0.15	0.30	0.91	2.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	19.70	2.07	0.00	0.00	0.52	1.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.26	1.88	0.00	0.21	0.00	1.47	0.00	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	21.65	1.50	0.15	0.30	0.30	1.80	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	24.08	2.75	0.69	0.00	0.69	2.06	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	18.63	2.63	0.00	0.00	0.19	1.88	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	16.43	1.91	0.11	0.21	0.11	1.91	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.35	1.94	0.00	0.00	0.00	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.89	3.31	0.00	0.00	0.00	1.98	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	16.48	1.12	0.00	0.25	0.00	1.24	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.62	1.48	0.00	0.74	1.11	2.22	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	15.57	2.47	0.00	0.49	0.00	1.24	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	18.29	1.37	0.00	0.14	0.14	1.92	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	22.84	2.89	0.00	0.00	0.64	4.18	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	19.48	2.74	0.00	0.00	0.00	1.52	0.00	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.30	1.54	0.70	0.42	0.28	1.26	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	23.82	1.42	0.71	0.36	0.71	4.62	0.00	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.70	0.97	0.00	0.00	0.00	1.94	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	12.60	1.24	0.31	0.00	0.16	1.40	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	22.56	2.51	1.07	0.00	0.00	1.79	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	18.62	2.61	0.00	0.00	0.33	2.29	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	11.77	0.71	0.00	0.00	0.47	1.65	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	20.54	1.86	0.12	0.12	0.25	3.47	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.57	1.54	0.00	0.00	0.00	1.02	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	19.99	1.49	0.00	0.00	0.00	2.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	43.05	2.27	0.00	0.00	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.95	5.37	0.00	0.00	0.00	3.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	23.75	3.71	0.00	0.00	0.00	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	27.93	2.54	0.42	0.00	0.00	2.96	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	17.58	3.52	0.00	1.41	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	21.48	1.87	0.93	0.00	0.93	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	22.67	0.52	0.52	0.00	0.52	3.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	29.74	4.76	0.00	0.00	0.00	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.39	2.49	0.00	0.23	0.45	3.17	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	30.83	2.04	0.29	0.00	0.00	2.04	0.00	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	32.41	2.25	0.00	0.00	0.00	1.80	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	28.32	3.39	0.68	0.14	0.14	0.68	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	20.03	1.54	0.00	0.00	0.51	4.11	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	35.99	2.47	0.00	0.00	0.71	1.76	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	35.31	2.67	0.67	0.00	0.00	2.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.51	1.02	0.51	0.00	0.00	1.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	33.88	3.74	0.00	0.27	0.00	1.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	35.90	2.83	0.00	0.19	0.57	2.83	0.00	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	25.16	3.07	0.61	0.00	0.00	2.45	0.00	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	34.25	4.08	0.82	0.82	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	34.57	2.29	0.83	0.00	0.42	2.50	0.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	26.34	3.92	0.00	0.00	0.28	2.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	22.67	3.09	0.00	0.00	0.00	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	33.38	3.48	0.00	0.00	0.00	2.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	25.41	2.09	0.00	0.30	0.60	3.29	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	32.09	4.98	1.11	0.00	0.00	1.66	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	29.69	1.77	0.00	0.00	0.35	2.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	33.56	3.69	0.37	0.00	0.00	1.84	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	21.87	0.00	0.00	0.00	0.00	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	27.25	2.30	0.00	0.00	0.38	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	28.31	1.13	0.00	0.57	0.57	1.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	33.64	2.46	0.00	0.00	0.00	2.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	28.02	3.62	0.00	0.00	0.45	3.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	23.70	3.59	0.00	0.00	0.00	1.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	21.66	4.48	0.00	0.00	0.00	2.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	29.36	2.60	0.74	0.00	1.11	1.49	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.52	3.02	0.43	0.00	0.00	2.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.98	1.71	0.00	0.00	0.86	1.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	24.32	3.66	0.33	0.00	0.00	2.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.13	3.02	0.60	0.00	0.60	1.81	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	19.91	3.55	0.00	0.00	1.42	1.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.94	1.72	0.00	0.00	1.03	3.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	26.30	3.76	0.00	0.00	0.00	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	27.61	2.69	0.00	0.00	0.67	2.02	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.52	2.59	0.74	0.00	0.74	2.22	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	19.77	2.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	2.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	29.61	1.20	0.80	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	22.53	2.18	0.73	0.00	0.00	2.91	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	26.06	1.53	0.77	0.00	0.00	3.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	24.66	0.99	0.00	0.00	0.00	4.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	21.64	0.94	0.00	0.00	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	22.12	4.53	0.50	0.00	0.50	2.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	25.23	3.15	0.45	0.00	1.35	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	1.72	0.00	0.00	1.72	3.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	26.72	2.67	0.00	0.45	0.00	2.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	21.12	2.74	0.00	0.00	0.39	1.56	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	21.11	1.98	0.00	0.66	0.00	1.98	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	22.83	2.08	0.52	0.52	0.00	4.67	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	30.19	1.75	0.00	0.00	0.00	1.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.16	2.24	0.00	0.00	0.00	1.68	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.06	3.53	0.00	0.00	0.44	3.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	24.30	3.09	0.00	0.00	0.00	2.31	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.28	3.54	0.00	0.00	1.52	1.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	30.76	3.84	0.00	0.48	0.00	2.40	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	27.03	2.78	0.40	0.00	0.00	2.39	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	25.52	3.65	0.61	0.00	0.61	2.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.91	4.15	0.00	0.00	0.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	29.26	3.04	0.00	0.00	0.38	3.42	0.00	0.00	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	27.37	1.55	0.52	0.00	0.52	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	18.74	4.23	0.00	0.00	0.00	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	34.54	3.80	0.32	0.00	0.32	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	20.26	2.13	0.00	0.00	0.00	3.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	15.52	4.60	0.00	0.00	0.57	2.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	19.54	3.09	0.00	0.00	0.51	2.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	28.29	4.95	0.71	0.00	0.00	2.83	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	23.83	6.81	0.00	0.00	0.57	1.13	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.87	2.91	0.42	0.00	0.83	2.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	20.36	3.13	0.00	0.00	0.00	3.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	22.13	4.18	0.42	0.00	0.00	2.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	30.20	4.18	0.46	0.46	0.00	2.79	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.73	4.01	0.67	0.00	0.00	4.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.59	4.28	0.00	0.00	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	33.14	7.68	0.00	0.00	0.00	2.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	16.52	5.51	0.00	0.92	0.92	2.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	23.12	0.89	0.00	0.00	1.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	32.48	7.41	0.00	0.00	0.00	2.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.87	8.44	0.00	0.00	0.00	3.83	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.96	2.19	0.00	0.00	0.00	3.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	24.95	5.35	0.00	0.00	0.00	2.67	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	25.74	5.20	0.00	0.00	0.26	4.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	26.52	6.63	0.00	0.00	0.66	5.30	0.00	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	2.08	2.08	0.00	0.00	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	55.16	4.56	0.91	0.00	0.46	3.87	0.23	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	20.37	4.40	0.37	0.73	0.00	2.20	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	52.17	3.93	0.39	0.92	0.52	3.41	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	18.59	3.19	0.00	0.00	0.53	1.59	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	12.83	1.74	0.16	0.00	0.48	1.58	0.16	0.00	0.16
Mallassez-derived cells, donor3	11930-125I4	20.01	3.20	0.00	0.28	0.42	3.06	0.00	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	26.31	2.89	0.30	0.20	0.20	3.19	0.00	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	27.80	2.90	0.00	0.00	0.29	2.32	0.00	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	20.95	0.75	0.00	0.00	0.00	1.75	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	66.44	40.68	1.36	6.10	2.03	15.59	3.39	0.00	0.00
Mast cell, donor1	11563-120D6	71.81	10.60	0.76	0.76	1.51	9.95	0.43	0.11	0.00
Mast cell, donor2	11565-120D8	60.92	7.13	0.59	0.30	0.30	4.75	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	61.91	4.50	0.45	0.45	0.23	2.93	0.23	0.23	0.23
Mast cell, donor4	11567-120E1	81.91	4.79	0.53	0.00	0.71	5.85	0.18	0.35	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	48.13	5.88	1.00	0.55	0.33	5.10	0.11	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	26.27	14.59	0.58	2.33	1.75	2.33	1.17	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	63.56	5.74	0.80	0.11	0.80	8.49	0.00	0.23	0.11
Mast cell, expanded, donor8	11941-126A6	73.98	6.53	0.67	0.67	0.50	5.36	0.00	0.17	0.33
Melanocyte - dark, donor1	11502-119F8	35.92	2.49	0.40	0.10	0.30	2.89	0.30	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	26.99	3.11	0.00	0.69	0.00	2.77	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	38.10	1.96	0.65	0.36	0.14	3.19	0.07	0.00	0.22
Melanocyte - light, donor1	11274-116H5	27.97	1.88	0.47	0.24	0.24	0.94	0.24	0.00	0.24
Melanocyte - light, donor2	11351-117H1	30.71	2.05	0.00	0.00	0.00	2.73	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	23.42	2.60	0.87	0.00	0.00	3.47	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	50.92	1.67	0.31	0.73	1.04	3.33	0.00	0.00	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	29.31	1.61	0.00	0.00	0.27	3.50	0.00	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	75.54	1.61	0.54	0.27	0.00	5.36	0.00	0.00	0.54
Meningeal Cells, donor1	11493-119E8	35.73	5.58	0.37	0.25	0.37	7.20	0.25	0.00	0.25
Meningeal Cells, donor2	11573-120E7	40.93	2.64	0.44	0.44	0.44	7.48	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	34.31	4.16	0.33	0.24	0.41	4.89	0.00	0.16	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	38.50	1.71	0.57	0.00	0.29	3.99	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	14.69	2.31	0.20	0.20	0.10	3.42	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	22.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	27.47	0.00	0.00	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	27.27	2.15	0.00	0.72	0.00	3.59	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	27.11	3.81	0.21	0.21	0.64	4.24	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	29.15	4.02	0.00	0.00	1.01	1.51	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	34.06	4.18	0.00	0.44	0.00	3.74	0.00	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	37.26	5.84	0.00	0.73	0.00	7.31	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	32.74	2.66	0.41	0.61	0.20	3.89	0.00	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	16.62	1.94	0.00	0.14	0.14	2.35	0.00	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	17.10	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	31.71	0.92	0.26	0.13	0.13	0.92	0.00	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.95	0.00	0.00	0.30	0.00	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	0.00	0.00	0.00	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	28.82	0.64	0.00	0.00	0.00	1.28	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.03	5.67	0.35	0.71	0.00	5.32	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	27.21	0.31	0.00	0.31	0.00	1.88	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	26.85	3.63	0.73	0.00	0.00	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	15.91	1.59	0.27	0.00	0.00	3.18	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	13.51	3.50	0.50	0.00	1.00	6.51	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	19.80	1.16	0.36	0.14	0.29	2.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	109.38	18.90	0.00	1.35	4.05	9.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	48.27	5.91	0.25	0.49	1.23	5.66	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	30.33	4.71	0.59	1.18	0.59	5.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	107.17	13.83	0.00	0.00	0.00	10.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	31.92	4.96	0.00	0.62	0.00	3.72	0.00	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	17.01	3.53	0.00	0.00	0.41	2.70	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	92.64	13.90	0.00	4.63	4.63	11.58	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	37.54	4.00	0.00	0.50	0.25	3.75	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	41.43	4.19	0.47	0.00	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	214.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	28.86	3.66	0.20	0.20	0.20	1.63	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.53	3.56	0.40	1.58	0.40	2.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	162.48	17.10	0.00	0.00	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.93	3.54	0.00	0.00	2.65	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	20.52	3.04	0.00	0.76	0.00	2.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	75.01	11.84	0.00	1.32	1.32	9.21	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	24.62	2.33	0.42	0.64	0.64	2.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	25.78	5.52	0.00	0.92	0.00	3.68	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	23.84	2.09	0.30	0.60	0.30	1.79	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	33.53	10.06	0.00	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	0.00	0.00	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	19.57	1.76	0.75	0.50	0.25	2.01	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	18.30	1.90	0.24	0.71	0.00	2.61	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	47.00	7.19	0.00	3.87	0.00	3.87	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.10	3.22	0.23	1.15	0.23	2.07	0.00	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	21.24	2.94	0.42	0.63	0.21	2.94	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	21.20	3.67	0.00	1.22	0.61	1.63	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	24.46	3.00	0.21	1.50	0.43	0.86	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.45	4.00	0.22	0.67	0.22	2.22	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	92.87	0.00	0.00	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	16.43	3.29	0.22	2.19	0.22	2.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	24.33	6.08	0.00	1.52	0.51	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	51.37	6.63	0.00	4.97	0.00	1.66	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	28.27	5.16	0.00	2.99	0.54	1.63	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	15.00	2.65	0.00	1.18	0.59	2.06	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	45.79	5.45	1.09	0.00	2.18	2.18	0.00	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	19.22	1.44	0.00	0.00	0.00	2.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.81	6.00	0.00	3.20	0.40	3.20	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	31.54	10.97	0.00	1.37	0.00	1.37	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.02	3.50	0.50	1.50	0.50	1.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	32.62	8.15	0.00	2.04	0.00	4.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	23.21	2.63	0.44	2.19	0.00	2.19	0.44	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	38.63	9.93	0.00	2.21	0.00	4.41	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	48.03	7.04	0.00	3.84	0.00	4.48	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	24.79	2.73	0.00	0.99	0.50	3.22	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	18.79	6.26	0.00	0.70	1.39	4.87	0.00	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	86.18	11.05	0.00	2.21	2.21	6.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	24.27	0.00	0.68	1.71	0.00	3.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	26.69	12.69	0.00	0.88	1.75	4.81	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	57.17	7.81	1.07	0.71	1.07	4.97	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	21.60	3.37	0.28	1.40	0.28	1.68	0.28	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	23.28	7.48	0.00	2.49	0.42	5.82	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	39.63	7.58	0.58	0.58	2.33	4.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	21.12	3.92	0.00	0.90	0.30	2.11	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	16.70	6.26	0.00	1.25	0.83	2.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	21.66	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	35.10	6.46	0.00	0.92	1.85	2.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	17.64	6.26	0.00	0.57	0.57	3.98	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	34.96	4.84	0.14	0.41	0.00	3.59	0.14	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	19.44	1.81	0.78	0.52	0.26	3.11	0.00	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	25.74	7.29	0.00	0.43	0.00	5.58	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	31.76	9.53	0.00	0.64	1.27	3.18	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	26.96	4.80	0.00	1.07	1.07	2.40	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	29.33	4.49	0.30	0.30	1.20	3.59	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	31.22	2.40	0.00	0.71	0.42	2.40	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	19.75	3.50	0.32	0.32	0.64	1.27	0.32	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.01	7.96	0.00	1.11	0.88	3.32	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	32.99	6.45	0.00	0.38	0.38	4.17	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	20.17	3.69	0.00	0.28	0.28	2.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	17.45	5.90	0.00	1.72	1.23	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	41.06	7.17	0.65	0.65	0.00	3.26	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	25.87	2.65	0.00	0.29	0.88	2.06	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	26.24	3.17	0.00	0.86	0.58	2.02	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	32.56	7.83	0.41	1.24	0.41	3.71	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	35.44	2.98	0.30	0.60	0.60	2.68	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	3.77	0.00	0.00	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	46.34	3.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	47.31	2.30	0.00	0.00	0.66	2.30	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	33.66	4.21	1.05	0.00	0.00	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	40.72	2.57	0.40	0.40	0.00	3.95	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	55.88	4.66	0.00	0.93	0.00	7.45	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	42.81	3.76	0.38	0.75	0.38	3.00	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	31.43	1.86	0.27	0.53	0.27	2.93	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	41.28	1.24	0.11	0.34	0.34	3.05	0.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	28.73	0.74	0.00	0.74	1.47	2.95	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	42.87	2.56	0.00	0.00	0.73	2.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	52.89	6.22	0.00	0.00	1.56	3.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	32.60	1.07	0.00	0.00	0.00	3.21	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	0.00	0.00	0.00	0.00	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	39.39	3.03	0.00	1.01	0.00	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	25.30	3.37	0.42	2.11	0.42	3.79	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	36.77	4.09	0.00	0.00	0.00	1.36	0.00	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	14.62	1.91	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	20.25	0.81	0.00	0.81	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	22.66	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	85.65	5.71	0.00	0.00	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	3.26	0.00	0.00	0.00	3.26	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	18.96	4.09	0.43	0.00	0.65	4.31	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	31.36	1.57	0.52	0.00	0.00	3.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	2.00	0.00	0.00	0.00	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.44	3.34	0.00	0.00	0.00	0.83	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	22.82	4.37	0.00	0.00	1.14	3.80	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	59.05	4.79	0.00	0.00	4.79	4.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	29.40	11.03	1.84	0.00	0.00	7.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.14	0.00	0.00	0.00	0.00	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	14.18	2.32	0.00	0.46	0.00	1.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	13.78	1.08	0.00	0.00	0.00	0.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.86	1.68	0.00	0.00	0.63	2.73	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.93	0.99	0.00	0.00	0.00	0.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.62	0.81	0.00	0.00	0.00	1.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.37	0.45	0.00	0.00	0.00	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.49	1.31	0.16	0.49	0.00	0.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.50	1.09	0.18	0.18	0.91	2.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.32	1.59	0.00	0.00	0.00	1.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.21	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.72	0.66	0.00	0.33	0.33	0.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	13.50	1.30	0.00	0.00	0.00	0.49	0.00	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	24.34	1.41	0.00	0.18	0.53	2.29	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	10.55	0.70	0.00	0.00	0.00	0.70	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.85	0.46	0.00	0.00	0.00	0.92	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	14.78	1.61	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	23.45	1.38	0.00	0.00	1.03	1.72	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	63.21	12.64	0.00	0.00	5.06	20.23	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.29	1.34	0.45	0.00	0.22	1.56	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	11.85	2.54	0.00	0.42	0.00	2.96	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.04	1.19	0.00	0.24	0.47	0.95	0.00	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	16.31	1.72	0.00	0.43	0.00	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	72.22	9.03	0.00	0.00	9.03	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	15.33	0.67	0.00	0.00	0.00	0.67	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.09	2.71	0.90	0.45	0.45	3.61	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.90	2.38	0.00	0.00	0.00	1.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	16.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.05	1.89	0.00	0.00	0.00	0.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.75	2.61	0.00	0.00	0.33	1.63	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.92	1.74	0.00	0.00	0.00	1.31	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	27.14	1.81	0.00	0.45	0.45	2.26	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	0.88	0.00	0.00	0.00	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.95	0.66	0.00	0.00	0.00	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	17.86	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.95	1.53	0.00	0.77	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	25.10	1.21	0.00	0.00	0.00	0.91	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	20.78	3.76	0.22	0.22	0.44	2.65	0.22	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	15.59	1.36	0.00	0.00	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	0.00	0.00	0.00	0.00	30.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	21.34	1.22	0.00	0.00	0.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.22	2.83	0.00	0.00	0.31	0.63	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	22.40	0.61	0.30	0.61	0.30	0.00	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.20	1.58	0.00	0.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	21.54	7.94	0.00	0.00	0.00	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	5.06	0.00	0.00	5.06	25.29	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	22.86	4.84	0.37	0.37	0.50	4.84	0.00	0.00	0.00
Myoblast, donor2	11322-117D8	32.99	4.22	0.38	0.19	0.58	5.37	0.19	0.00	0.00
Myoblast, donor3	11398-118D3	27.41	2.69	0.00	0.17	0.00	3.70	0.00	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	60.12	0.73	1.31	0.00	0.00	2.63	0.00	0.00	0.29
Natural Killer Cells, donor1	11230-116C6	58.43	6.46	0.31	0.00	0.31	2.46	0.62	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	49.15	6.03	0.90	0.00	0.90	2.71	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	55.40	4.23	0.55	0.18	0.37	0.74	0.18	0.37	0.18
Neural stem cells, donor1	11275-116H6	71.86	10.53	0.73	1.09	0.73	13.07	0.36	0.36	0.00
Neural stem cells, donor2	11352-117H2	152.13	26.96	3.85	1.93	1.93	13.48	0.00	1.93	0.00
Neurons, donor1	11494-119E9	95.58	28.45	1.14	1.14	4.55	15.93	1.14	0.00	1.14
Neurons, donor2	11574-120E8	110.74	16.73	1.76	0.66	1.10	14.97	0.00	0.88	0.66
Neurons, donor3	11655-122E8	72.35	12.33	0.82	0.82	4.93	10.69	0.00	3.29	0.00
Neutrophils, donor1	11233-116C9	72.38	6.50	0.00	1.86	0.00	3.71	0.00	0.00	7.42
Neutrophils, donor2	11314-117C9	60.88	2.90	0.00	2.90	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	51.31	7.33	0.00	1.22	2.44	3.67	0.00	0.00	6.72
Nucleus Pulposus Cell, donor1	11252-116F1	37.40	1.31	0.83	0.12	0.00	2.14	0.00	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	25.40	1.63	0.00	0.00	0.00	0.98	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	20.66	1.00	0.00	0.00	0.20	3.21	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	17.07	1.24	0.14	0.14	0.14	1.93	0.00	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	18.53	1.88	0.29	0.00	0.43	2.03	0.00	0.29	0.29
Olfactory epithelial cells, donor3	11935-125I9	16.57	1.48	0.00	0.00	0.34	2.50	0.00	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	32.92	2.63	0.49	0.49	0.58	4.29	0.00	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	24.67	1.20	0.00	0.60	0.00	1.20	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	29.14	2.77	0.00	0.43	0.00	3.62	0.00	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	27.43	1.14	0.00	0.00	0.00	1.14	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.86	4.97	0.00	0.00	0.00	1.24	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	17.59	2.93	0.39	0.00	0.20	4.89	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	32.31	5.62	0.00	0.00	0.70	4.21	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	29.86	5.33	0.36	0.53	0.36	5.15	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	31.00	2.19	0.42	0.25	0.42	4.80	0.17	0.17	0.17
Pericytes, donor1	11491-119E6	19.81	2.45	0.11	0.11	0.11	3.00	0.00	0.11	0.00
Pericytes, donor2	11571-120E5	22.18	2.72	0.00	0.23	0.00	3.85	0.45	0.00	0.00
Pericytes, donor3	11652-122E5	20.96	3.66	0.41	0.20	0.41	1.83	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	35.15	1.47	0.34	0.11	0.11	3.73	0.00	0.00	0.00
Perineurial Cells, donor2	11579-120F4	33.03	2.76	0.37	0.46	0.09	2.76	0.28	0.00	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	71.08	6.69	0.00	0.00	0.32	2.55	0.00	0.64	1.91
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	62.19	3.67	0.73	0.24	0.49	4.16	0.24	0.00	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	61.99	2.72	0.26	0.00	0.39	2.07	0.13	0.00	0.39
Placental Epithelial Cells, donor1	11278-116H9	17.22	2.15	0.00	0.00	0.24	1.67	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	13.31	2.22	0.00	0.00	0.00	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	19.83	1.96	0.59	0.00	0.20	0.98	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	19.30	2.53	0.00	0.00	0.00	0.95	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	17.26	2.25	0.56	0.19	0.19	0.56	0.00	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	6.53	1.31	0.39	0.39	0.13	1.57	0.13	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	22.06	4.05	0.00	0.00	0.23	2.48	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	22.70	2.77	0.11	0.00	0.64	2.77	0.21	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	21.39	2.18	0.44	0.44	0.00	1.31	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	26.64	5.44	0.14	0.29	0.14	3.44	0.00	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	15.75	1.97	0.00	0.98	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	13.82	5.53	0.00	0.31	0.31	3.07	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	24.26	4.78	0.35	0.71	0.53	4.78	0.00	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	27.76	5.79	0.51	0.51	0.00	4.60	0.17	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	26.64	4.19	0.09	0.28	0.56	4.28	0.09	0.00	0.00
Preadipocyte - visceral, donor2	11357-117H7	14.27	1.84	0.46	0.00	0.00	3.68	0.46	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	15.88	3.76	0.10	0.42	0.42	2.61	0.00	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	23.38	1.21	0.30	0.15	0.30	3.62	0.15	0.00	0.30
Prostate Epithelial Cells, donor2	11331-117E8	14.90	3.93	0.00	0.00	0.27	3.66	0.00	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	24.62	0.98	0.43	0.31	0.31	1.10	0.12	0.00	0.12
Prostate Stromal Cells, donor1	11254-116F3	25.86	5.01	0.11	0.11	0.57	5.13	0.00	0.23	0.11
Prostate Stromal Cells, donor2	11332-117E9	28.15	4.66	0.72	0.18	0.90	4.48	0.36	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	34.52	3.96	0.21	0.31	0.31	4.48	0.10	0.00	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	34.31	2.92	0.00	0.36	0.36	2.19	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	26.48	1.73	0.42	0.00	0.14	1.87	0.00	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	31.45	2.03	0.00	0.00	0.00	3.55	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	29.88	0.71	0.71	0.00	1.42	2.13	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	27.10	2.22	0.00	0.00	0.11	2.65	0.00	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.74	3.40	0.68	0.68	0.68	2.04	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	25.34	2.83	0.00	0.27	0.54	3.77	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	34.41	2.66	0.00	0.67	0.89	3.77	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	22.63	0.00	0.00	0.00	2.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	29.93	5.72	0.22	0.22	0.44	3.52	0.00	0.22	0.44
Renal Mesangial Cells, donor2	11598-120H5	31.98	1.88	0.00	0.00	1.25	1.25	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	23.58	1.66	0.28	0.28	0.00	1.11	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	34.63	2.42	0.27	0.00	0.00	5.10	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.51	1.69	0.00	0.00	0.00	1.27	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	32.21	2.12	0.39	0.19	0.00	4.05	0.00	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	32.67	0.52	0.78	0.26	0.00	2.33	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	25.58	1.14	0.00	0.28	0.57	1.99	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	32.93	1.03	0.00	1.03	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	17.06	2.26	1.00	0.00	0.75	4.27	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	54.12	3.61	0.40	0.27	0.00	2.41	0.00	0.67	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	49.14	7.15	0.00	0.89	0.00	1.79	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	18.16	3.85	0.55	0.00	1.10	3.85	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	39.44	6.96	1.16	0.00	0.58	6.38	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	35.63	8.71	0.13	0.26	0.13	10.53	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	53.82	4.67	0.40	0.50	0.89	9.33	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	50.64	9.82	1.12	0.56	0.67	10.93	0.00	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	40.31	7.57	0.00	0.87	0.74	11.41	0.12	0.00	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	47.20	6.18	0.58	0.58	0.70	10.14	0.12	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	56.40	8.78	0.92	0.46	0.92	9.94	0.23	0.00	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	37.65	5.75	0.14	0.27	0.41	7.39	0.00	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	48.26	7.56	0.15	0.15	0.76	9.98	0.45	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	56.44	8.96	0.90	1.08	0.54	10.57	0.00	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	31.99	5.02	0.00	0.29	0.29	8.61	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	48.40	5.79	0.21	0.54	0.32	8.05	0.11	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	50.45	8.85	0.00	0.66	0.44	9.29	0.00	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	35.94	4.59	0.38	0.38	0.19	8.22	0.00	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	53.85	8.38	0.47	0.47	0.47	10.15	0.19	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	52.61	8.27	1.32	0.00	1.13	11.27	0.00	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	39.55	7.03	0.00	0.40	1.06	10.09	0.00	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	51.79	7.79	0.58	0.58	0.68	9.64	0.29	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	53.09	6.49	0.38	0.57	0.19	9.93	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	37.27	6.83	0.11	0.53	0.64	8.01	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	49.89	5.61	0.28	0.00	0.56	11.49	0.56	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	58.96	8.89	0.51	1.37	0.34	9.40	0.00	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.74	5.83	0.18	0.55	0.91	9.30	0.00	0.18	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	45.74	7.48	0.86	0.00	0.61	8.46	0.12	0.25	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	56.55	7.12	0.54	0.13	1.07	8.73	0.13	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	31.14	5.43	0.00	0.47	0.47	4.72	0.00	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	46.63	6.94	0.20	0.79	0.60	12.10	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	51.21	7.95	0.94	0.70	0.70	9.12	0.23	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	35.04	4.56	0.00	0.21	0.83	5.60	0.00	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	51.54	9.29	0.88	0.66	1.33	11.06	0.22	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	49.51	8.15	1.04	0.63	1.46	6.27	0.21	0.00	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	36.88	7.27	0.00	0.40	0.81	7.13	0.13	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	61.31	8.51	0.51	0.51	1.02	6.47	0.17	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	49.55	8.29	0.77	0.96	0.19	9.25	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	36.79	5.33	0.34	0.17	0.69	6.88	0.00	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	59.39	8.09	0.82	0.27	0.82	8.37	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	57.62	8.21	1.15	0.66	0.99	11.98	0.49	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	41.76	4.26	0.34	1.19	0.34	7.67	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	55.04	6.95	0.15	0.89	0.89	7.10	0.00	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	49.58	6.13	0.53	0.27	0.27	6.66	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	34.29	8.02	0.00	0.28	0.00	6.36	0.00	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	45.72	7.86	0.24	0.71	0.24	8.10	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	49.18	7.26	1.01	0.81	0.40	8.46	0.60	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	26.93	5.84	0.00	0.38	0.38	4.61	0.09	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	43.67	14.32	0.70	0.35	0.70	8.73	0.00	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	44.12	6.65	0.60	0.00	0.60	5.74	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	22.89	5.02	0.00	0.37	0.37	4.90	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	73.50	18.05	0.87	0.58	0.58	8.59	0.29	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	45.02	6.69	0.61	1.22	0.61	5.48	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	26.22	4.82	0.00	0.00	0.00	5.43	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.24	5.65	0.23	0.23	0.68	6.56	0.00	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	44.63	8.69	0.90	0.60	0.60	3.59	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	27.98	7.20	0.24	0.24	0.24	4.49	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	39.70	7.26	0.64	0.43	1.07	7.68	0.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	53.49	11.42	1.20	0.00	0.00	7.21	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	25.39	3.20	0.00	0.00	0.00	4.14	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	26.95	2.63	0.22	0.00	0.00	2.19	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	37.25	2.74	0.55	0.00	0.00	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	18.84	0.92	0.00	0.00	0.00	3.68	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	24.94	1.24	0.21	0.00	0.00	1.03	0.00	0.21	0.00
Sertoli Cells, donor1	11255-116F4	13.25	3.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	2.82	0.00	0.00	0.00	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	34.49	2.90	0.18	0.18	0.44	3.70	0.00	0.00	0.00
Skeletal Muscle Cells, donor2	11358-117H8	13.01	5.06	0.00	0.00	0.00	2.17	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	20.06	2.51	0.00	0.00	0.84	6.69	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	31.58	2.83	0.16	0.47	0.31	4.56	0.16	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	34.19	2.68	0.00	0.89	0.30	2.82	0.15	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	30.63	4.00	0.00	0.62	0.46	3.69	0.15	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	35.66	1.13	0.76	0.13	0.00	2.77	0.00	0.00	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	41.81	1.85	0.43	0.29	0.43	3.14	0.00	0.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	50.89	4.07	0.50	0.89	0.50	4.76	0.10	0.10	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	38.08	6.15	0.51	0.76	0.76	6.32	0.08	0.00	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	26.06	3.62	0.72	0.00	0.00	4.34	0.00	0.00	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	17.06	2.06	0.14	0.28	0.55	3.44	0.28	0.14	0.00
Skin - palm, donor1	10286-104F7	56.41	5.37	0.00	0.00	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	16.00	0.86	0.00	0.29	0.00	1.44	0.29	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	28.63	2.45	0.82	0.00	2.45	0.82	0.00	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.73	1.56	0.00	0.00	0.26	1.69	0.00	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	21.82	3.06	0.56	0.00	0.70	4.31	0.00	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	30.38	3.09	0.14	0.14	0.14	3.38	0.00	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	35.31	4.44	0.42	0.21	0.63	3.17	0.00	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	33.35	3.52	0.60	0.30	0.15	2.70	0.15	0.07	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	15.43	1.54	0.00	0.00	0.31	3.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	5.11	1.78	0.00	0.44	0.00	2.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	22.34	4.70	0.00	0.00	0.00	2.94	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	28.29	2.21	0.00	0.22	0.66	3.31	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	19.30	3.94	0.00	0.39	0.79	3.94	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	15.45	2.32	0.00	0.77	0.77	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	31.02	0.00	0.00	0.00	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	21.29	2.66	0.67	0.27	0.13	3.59	0.27	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	27.04	2.66	0.44	0.22	0.66	3.77	0.44	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	19.97	3.58	0.00	0.38	0.64	3.58	0.13	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.98	4.23	0.00	0.00	0.00	4.23	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	27.47	3.25	0.59	0.00	0.59	3.54	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	23.06	2.56	0.14	0.28	0.00	2.85	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	24.56	2.44	0.16	0.00	0.33	3.25	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	34.10	1.52	0.00	0.00	0.61	1.52	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	21.72	1.52	0.00	0.00	0.51	1.77	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	73.45	0.00	0.00	0.00	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.06	1.43	0.00	0.00	0.00	4.77	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	24.63	1.62	0.29	0.00	0.29	2.06	0.00	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.27	2.15	0.22	0.22	0.22	2.15	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	29.60	2.31	0.21	0.10	0.21	3.25	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	21.35	3.40	0.00	0.62	0.31	2.63	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	15.09	4.31	0.00	1.08	0.00	5.39	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.05	4.78	0.30	0.00	0.90	3.29	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	30.38	1.71	0.34	0.00	0.00	3.76	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	34.32	0.79	0.31	0.31	0.16	2.20	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	20.73	2.31	0.20	0.30	0.10	2.62	0.10	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.93	4.78	0.23	0.23	2.50	3.19	0.23	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.08	2.42	0.00	0.00	0.60	3.02	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	29.67	5.30	0.26	0.00	0.79	4.50	0.26	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.44	3.06	0.00	0.27	0.00	2.66	0.13	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	30.05	4.51	0.50	0.00	0.38	3.63	0.00	0.13	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.25	3.04	0.00	0.00	0.00	0.76	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.95	4.67	0.15	0.45	1.51	5.58	0.00	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	21.00	6.75	0.75	0.75	0.00	2.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	164.11	1.29	0.00	0.00	2.58	15.51	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	15.81	2.33	0.47	0.00	0.93	2.79	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	19.19	2.52	0.50	0.00	1.01	2.52	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.34	3.13	0.00	0.00	0.00	1.88	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	19.17	2.06	0.00	0.29	0.29	2.36	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	38.24	4.00	0.42	0.33	0.58	4.33	0.00	0.00	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	36.44	1.40	0.47	0.00	0.47	2.80	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12.81	2.30	0.29	0.00	0.00	3.02	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	18.36	2.04	0.00	0.25	0.51	4.33	0.00	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	13.91	2.63	0.19	0.19	0.38	3.38	0.00	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	29.07	1.26	0.28	0.14	0.14	3.49	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	24.55	1.84	0.25	0.08	0.25	2.93	0.17	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	13.81	0.48	0.00	0.00	0.00	1.43	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	17.13	1.71	0.00	0.00	0.49	3.67	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.70	3.98	0.00	0.22	0.66	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	18.43	2.05	0.59	0.00	0.29	3.51	0.00	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	28.77	1.55	0.00	0.00	0.39	1.17	0.00	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.81	0.79	0.00	0.00	0.53	2.12	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.65	0.00	0.37	0.37	0.00	1.86	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.92	2.87	0.00	0.36	0.00	2.52	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.90	1.70	0.00	0.00	0.00	1.70	0.00	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.15	3.94	0.00	0.00	1.18	2.76	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	16.76	0.76	0.00	0.00	0.25	2.29	0.00	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	29.15	2.00	0.00	0.80	0.00	1.20	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	21.32	1.25	0.00	0.00	0.42	0.84	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	17.42	1.38	0.00	0.00	0.00	0.92	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	17.17	4.21	0.34	0.50	0.00	2.69	0.50	0.00	0.00
Synoviocyte, donor2	11368-117I9	26.99	2.51	0.17	0.00	0.17	2.68	0.00	0.34	0.17
Synoviocyte, donor3	11440-118H9	18.77	0.67	0.22	0.00	0.22	1.56	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	47.88	4.65	0.71	0.36	0.36	4.29	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	25.77	1.98	0.00	0.00	0.00	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	31.72	2.55	0.46	0.00	0.46	3.01	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	29.68	1.58	0.22	0.07	0.22	3.87	0.00	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	18.56	0.00	0.00	0.77	0.39	2.32	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	1.72	0.00	0.00	0.00	0.00	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	55.61	3.20	0.74	0.62	0.37	3.32	0.12	0.12	0.00
Urethra, donor2	10319-105A4	50.36	3.60	0.00	0.00	0.00	5.40	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	17.53	0.80	0.27	0.00	0.00	1.59	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	18.83	1.20	0.40	0.00	0.00	2.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	17.65	1.38	0.23	0.23	0.00	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	19.84	1.56	0.22	0.00	0.00	1.11	0.00	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	55.17	5.34	0.89	0.00	0.00	8.01	0.00	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	45.75	2.86	0.00	0.00	0.00	4.29	1.43	0.00	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	65.71	2.74	0.00	0.68	2.05	2.05	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	60.95	4.48	0.69	0.34	0.69	4.13	0.34	0.00	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	61.59	6.39	1.16	0.00	0.00	4.07	0.00	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	42.69	7.29	0.00	2.08	0.00	2.08	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	36.71	7.34	0.00	0.92	0.00	5.51	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	67.55	4.56	0.91	0.00	0.91	2.74	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	38.86	2.59	0.25	0.49	0.37	6.54	0.12	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	73.04	3.52	0.88	0.00	0.88	13.20	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	58.10	5.31	0.56	0.00	0.56	5.03	0.56	0.56	0.28
achilles tendon, donor2	10292-104G4	39.26	2.07	0.00	2.07	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	44.62	2.80	0.76	0.76	2.55	4.59	0.00	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	74.53	5.80	1.16	0.00	0.70	6.50	0.46	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	59.24	8.55	0.95	0.12	0.12	4.15	0.12	0.36	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	59.32	7.62	0.54	0.27	0.54	5.71	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	106.25	4.50	1.12	0.56	2.53	8.15	0.00	0.00	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	79.94	8.67	1.90	0.21	1.69	9.94	0.85	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	114.06	8.17	3.27	1.09	2.45	9.53	0.54	1.36	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	107.96	5.29	1.32	0.88	0.88	4.41	0.44	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	94.74	2.45	1.23	0.00	1.23	7.35	0.00	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	101.73	3.49	1.16	0.39	1.55	8.15	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	77.46	3.50	1.47	0.00	1.47	5.70	0.18	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	171.62	27.30	0.00	0.00	0.00	11.70	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	77.38	21.84	0.70	0.23	5.11	12.32	0.00	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	152.49	8.28	0.78	0.78	1.29	12.69	0.00	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	109.59	3.21	0.58	0.29	0.58	7.31	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	71.57	1.86	0.00	0.00	0.46	0.93	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	89.65	3.70	0.00	0.41	0.00	9.87	0.00	0.41	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	111.42	3.99	2.15	0.00	0.31	2.46	0.00	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	91.32	2.56	1.71	0.85	0.85	3.84	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	99.78	4.55	0.91	0.30	0.30	4.25	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	107.35	6.02	1.93	0.00	0.00	5.30	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	77.07	3.79	0.67	0.22	1.78	6.90	0.00	0.22	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	80.72	8.34	1.67	3.34	0.67	7.00	0.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	128.22	5.57	0.00	1.86	3.72	16.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	71.57	7.91	0.38	0.38	2.64	9.04	0.75	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	127.35	12.21	3.05	0.44	1.31	17.45	0.00	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	166.83	1.87	0.00	1.87	1.87	7.50	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	64.76	3.53	0.24	0.00	0.24	2.83	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	50.10	5.58	0.78	0.31	0.16	3.57	0.00	0.00	0.16
adipose, donor1	10184-103D4	49.26	1.76	0.59	0.00	0.59	5.28	0.00	0.00	0.00
adipose, donor2	10185-103D5	33.66	2.03	0.41	0.00	0.41	4.06	0.00	0.41	0.00
adipose, donor3	10186-103D6	54.19	1.91	0.27	0.00	0.27	6.26	0.00	0.54	0.54
adipose, donor4	10187-103D7	86.68	0.87	0.87	0.00	2.60	7.80	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	81.59	7.58	0.79	0.32	0.47	8.52	0.00	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	50.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	47.89	2.93	1.07	0.00	0.27	4.54	0.00	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	69.67	3.22	0.71	0.00	1.07	3.93	0.00	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	25.04	4.64	0.46	0.00	0.23	1.62	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	37.19	1.69	0.34	0.34	0.00	1.69	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	20.03	3.24	0.29	0.29	0.00	1.47	0.00	0.00	0.88
amygdala - adult, donor10196	10167-103B5	115.02	34.39	3.56	5.93	5.93	24.90	0.00	2.37	0.00
amygdala, adult, donor10252	10151-102I7	252.04	49.48	3.65	2.23	4.46	23.12	0.41	0.81	1.22
amygdala, newborn, donor10223	10360-105E9	72.30	18.72	1.61	10.01	5.16	15.82	0.32	0.32	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	28.52	1.66	0.64	0.25	0.00	1.91	0.00	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	42.58	3.53	0.44	0.22	0.44	6.18	0.22	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	59.12	4.34	1.00	1.00	2.34	12.03	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	52.37	4.90	0.59	0.20	0.78	2.55	0.39	0.00	0.20
appendix, adult	10189-103D9	91.60	3.88	0.78	1.16	0.78	5.43	1.16	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	62.25	1.03	0.00	0.34	0.34	6.53	0.00	0.00	0.69
artery, adult	10190-103E1	111.41	8.15	1.36	0.00	1.36	10.87	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	44.33	2.32	0.29	0.72	0.14	3.91	0.00	0.00	0.14
b cell line:RPMI1788	10427-106D4	34.05	4.01	0.15	0.15	0.30	5.06	0.00	0.00	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	15.81	4.16	0.00	0.00	0.00	1.66	0.28	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	25.70	3.67	0.20	0.10	0.20	2.98	0.10	0.00	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	39.84	2.68	0.50	0.17	0.17	4.35	0.00	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	62.08	0.56	0.56	0.00	0.56	3.36	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	67.90	4.56	0.98	0.33	0.43	3.37	0.00	0.43	0.00
blood, adult, pool1	10053-101G8	37.65	2.21	0.00	0.00	0.00	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	24.83	2.57	0.00	0.86	0.00	1.71	0.00	0.00	0.00
bone marrow, adult	10192-103E3	66.81	7.42	1.35	0.67	0.67	9.45	0.00	0.00	1.35
brain, adult, donor1	10084-102B3	140.43	27.68	1.03	2.05	5.13	22.55	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	160.69	31.96	3.56	1.78	2.34	29.18	1.34	0.78	0.45
brain, fetal, pool1	10085-102B4	104.18	21.37	2.67	2.67	0.00	29.39	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	72.68	7.27	1.32	0.33	0.00	4.29	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	59.91	2.87	1.37	0.25	0.00	3.74	0.00	0.12	0.25
breast, adult, donor1	10080-102A8	35.36	2.53	0.00	0.00	0.00	0.00	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	42.81	2.54	0.25	0.00	0.25	3.05	0.13	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	56.59	3.71	0.62	0.00	1.24	3.40	0.31	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	38.91	2.76	1.38	0.69	0.23	4.14	0.00	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	35.10	2.91	0.24	0.24	0.48	4.36	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	63.00	3.76	1.41	0.00	1.41	8.46	0.47	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	66.50	3.06	0.66	0.11	0.33	3.17	0.00	0.55	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	42.78	6.02	0.63	0.00	0.63	5.07	0.00	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	70.27	2.40	0.80	0.00	0.80	15.17	0.00	0.27	0.53
caudate nucleus - adult, donor10196	10177-103C6	155.43	21.88	0.00	2.30	2.30	14.97	0.00	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	201.80	46.52	4.52	1.67	3.35	31.46	0.84	0.84	0.84
caudate nucleus, adult, donor10258	10379-105H1	157.41	33.62	3.06	0.76	2.29	22.92	0.00	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	91.56	23.44	1.46	2.93	4.76	22.71	0.00	0.73	4.03
cerebellum - adult, donor10196	10173-103C2	145.66	8.74	0.00	0.00	2.91	23.31	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	228.46	23.91	4.27	0.43	2.35	36.51	0.00	1.49	0.43
cerebellum, adult, pool1	10083-102B2	92.79	8.62	0.69	0.00	2.41	16.90	0.34	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	132.85	12.45	4.15	0.00	9.96	46.50	0.00	0.83	1.66
cerebral meninges, adult	10188-103D8	200.96	45.89	4.29	3.03	5.55	40.85	0.76	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	119.13	16.81	0.00	0.00	3.65	11.69	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	71.60	2.59	0.86	0.14	0.72	9.92	0.14	0.29	0.43
cervical cancer cell line:ME-180	10553-107I4	18.39	3.81	0.17	0.17	0.17	1.33	0.33	0.00	0.00
cervix, adult, pool1	10013-101C4	88.82	3.78	0.84	0.10	0.21	5.67	0.10	0.00	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	27.03	4.32	0.56	0.14	0.70	3.48	0.42	0.14	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	1.31	0.00	0.00	1.31	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	55.30	2.98	0.50	0.25	0.25	4.23	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	46.82	0.99	0.49	0.00	0.49	2.71	0.00	0.12	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	32.26	0.47	0.00	0.24	0.00	2.13	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	18.23	0.57	0.00	0.00	0.28	0.57	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	26.65	3.78	0.20	0.20	0.40	3.48	0.30	0.00	0.10
chorionic membrane cells, donor3	12240-129G8	21.98	1.65	0.00	0.00	0.55	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	46.45	3.03	2.02	0.00	5.05	4.04	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	82.03	4.42	0.58	0.58	0.77	4.99	0.00	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	99.47	6.34	1.06	0.84	4.86	9.71	0.42	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	124.29	8.22	2.05	1.54	2.31	13.87	0.00	0.00	2.82
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	116.59	7.74	2.18	2.42	0.97	8.71	0.00	0.00	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	96.71	8.55	2.24	1.83	1.02	11.61	0.20	0.20	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	88.04	4.42	2.06	0.59	0.59	12.07	0.00	0.29	2.36
chronic myelogenous leukemia cell line:KU812	10409-106B4	126.40	7.56	2.09	0.26	1.04	13.03	0.00	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	35.89	2.06	0.46	0.23	0.23	6.17	0.00	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	20.65	3.12	0.35	0.00	0.35	1.56	0.00	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	30.02	3.84	0.00	0.00	0.55	2.93	0.18	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	98.82	4.18	0.76	0.38	0.00	4.56	0.00	0.00	0.38
colon, adult, donor1	10082-102B1	36.89	2.38	0.00	1.19	0.00	7.14	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	67.92	3.53	0.94	0.24	0.24	3.29	0.00	0.12	0.24
colon, fetal, donor1	10070-101I7	35.23	3.71	0.00	0.00	0.00	2.47	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	696.69	41.25	4.58	0.00	0.00	45.84	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	17.42	3.82	0.00	0.42	0.00	2.12	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	21.28	5.43	0.15	0.75	0.15	2.87	0.15	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	20.45	2.82	0.42	0.42	0.42	3.38	0.14	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	171.04	19.13	2.99	1.66	1.55	20.34	0.44	1.11	0.88
cruciate ligament, donor2	10295-104G7	59.97	2.43	0.00	0.81	0.00	7.29	0.81	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	53.77	4.01	0.00	0.00	0.00	6.42	0.00	0.80	0.80
diencephalon, adult	10193-103E4	131.27	16.80	1.92	2.64	3.84	18.48	0.72	0.48	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	58.55	2.07	0.00	0.00	1.15	3.90	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	46.16	5.39	1.28	0.26	0.00	4.62	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.63	6.02	0.48	1.20	0.96	7.22	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	90.20	6.98	0.00	1.50	0.00	6.98	0.00	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	40.33	5.76	0.00	0.00	0.00	2.88	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	64.00	4.41	0.74	0.00	1.47	6.62	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	95.80	7.35	1.49	0.91	0.50	7.35	0.08	0.41	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	30.20	8.44	0.67	3.11	2.00	4.22	0.00	0.00	6.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	35.11	5.73	0.86	0.72	0.29	3.87	0.00	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	39.46	0.62	0.62	0.62	0.00	4.32	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	33.90	0.91	0.00	0.00	0.00	2.72	0.00	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	45.39	2.16	0.31	0.00	0.31	3.40	0.00	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	45.97	5.25	0.00	0.00	1.31	3.94	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	35.87	9.39	0.00	0.00	1.34	9.05	0.67	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	53.10	8.88	0.36	0.18	0.54	8.16	0.18	0.18	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	25.73	4.50	0.00	0.00	0.64	4.34	0.00	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	49.58	5.67	1.22	0.56	0.22	4.67	0.00	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	53.23	3.63	1.10	0.22	0.33	7.04	0.11	0.11	0.11
epididymis, adult	10197-103E8	70.33	8.79	1.05	0.63	0.21	4.60	0.00	0.00	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	34.42	0.53	0.89	0.18	0.00	4.44	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	31.07	1.57	0.00	0.00	0.39	1.97	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	49.41	4.32	0.00	0.26	0.79	6.16	0.13	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	44.19	3.64	0.59	0.10	0.49	5.41	0.00	0.00	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	48.06	4.15	0.45	0.00	0.90	4.82	0.22	0.11	0.34
esophagus, adult, pool1	10015-101C6	63.18	3.40	0.53	0.32	0.42	2.23	0.21	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	77.15	4.76	1.13	0.88	0.63	5.39	0.13	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	67.61	2.41	0.00	0.00	0.00	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	42.08	8.42	0.00	0.00	0.00	8.42	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	74.41	2.98	0.00	0.00	1.49	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	48.15	8.03	0.00	0.00	0.00	4.59	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	106.39	10.20	0.00	0.00	4.37	4.37	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	60.00	4.58	0.76	0.25	0.51	6.61	0.25	1.02	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	29.75	2.82	0.51	0.38	0.51	2.69	0.00	0.00	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	42.74	3.09	0.24	0.47	0.47	5.70	0.00	0.47	0.24
frontal lobe, adult, pool1	10040-101F4	190.65	46.07	4.22	5.16	4.79	35.93	1.22	1.78	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	37.23	4.20	0.00	0.00	0.00	2.40	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	41.05	2.47	1.10	0.00	0.27	3.57	0.00	0.09	0.27
gall bladder, adult	10198-103E9	74.12	3.62	0.48	0.72	0.48	3.86	0.00	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	47.24	3.76	0.54	0.54	0.00	1.07	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	56.02	3.36	0.00	0.00	0.37	2.61	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	16.05	4.01	0.21	0.21	0.21	1.48	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	71.37	1.55	0.97	0.39	0.77	4.64	0.19	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	39.19	4.43	0.00	0.00	0.49	7.38	0.16	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	50.34	2.75	1.83	0.00	0.00	13.73	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	50.49	3.66	0.46	0.23	0.91	4.80	0.23	0.23	0.46
giant cell carcinoma cell line:LU65	10487-107B1	40.96	1.72	0.80	0.11	0.11	5.62	0.11	0.11	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	43.25	3.22	0.28	0.28	0.42	4.62	0.14	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	40.16	5.24	0.25	0.00	1.00	3.49	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	23.75	4.12	0.21	0.00	0.32	4.54	0.00	0.21	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	25.56	4.21	0.28	0.00	0.70	2.95	0.00	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	37.53	5.19	0.88	0.00	0.00	3.53	0.22	0.22	0.00
glioma cell line:GI-1	10413-106B8	28.41	1.17	0.29	0.00	0.59	0.88	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	107.88	20.41	2.92	1.46	2.92	13.12	0.73	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	288.52	23.19	3.42	1.22	3.17	24.17	1.71	0.98	1.95
globus pallidus, adult, donor10258	10367-105F7	172.52	23.28	4.11	1.37	0.00	8.22	2.74	1.37	2.74
globus pallidus, newborn, donor10223	10364-105F4	74.08	12.26	0.53	1.60	2.13	12.26	0.00	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	672.96	39.15	4.89	2.45	4.89	14.68	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	21.86	10.93	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	83.63	5.23	0.00	0.00	0.00	0.00	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	24.64	0.96	0.32	0.00	0.00	2.24	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	44.07	2.30	0.00	0.00	0.92	3.21	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	35.21	1.83	0.00	0.00	0.46	2.74	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	34.78	1.29	0.00	0.00	0.64	1.93	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	17.25	2.87	0.00	0.00	1.44	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	43.21	2.06	0.00	0.00	1.37	4.80	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	133.52	14.35	1.10	0.00	5.52	18.76	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	27.87	4.31	0.00	0.00	0.29	2.87	0.00	0.29	0.29
heart - mitral valve, adult	10205-103F7	78.33	8.97	0.30	0.60	0.90	9.87	0.00	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	94.39	10.98	0.78	0.78	1.31	5.49	0.00	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	108.24	3.33	0.83	0.00	0.83	5.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	44.28	1.63	0.20	0.41	0.61	2.45	0.00	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	54.93	4.26	0.43	0.00	0.43	5.54	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	99.58	9.43	0.92	0.23	0.69	7.36	0.00	0.00	0.46
heart, fetal, pool1	10046-101G1	102.17	8.52	1.23	0.31	0.92	10.88	0.41	0.72	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	18.51	1.85	0.00	0.00	0.62	0.62	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	45.19	1.19	0.00	1.19	1.19	2.38	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	64.53	5.52	0.44	0.44	0.66	10.28	0.00	0.11	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	70.15	5.83	0.36	0.12	0.49	11.77	0.12	0.00	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	72.76	5.46	0.20	0.20	0.81	11.22	0.20	0.10	0.40
hepatoma cell line:Li-7	10484-107A7	34.70	3.34	0.11	0.11	0.22	4.34	0.00	0.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	59.90	3.72	0.40	0.00	0.60	4.92	0.10	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	127.75	24.60	0.95	4.73	1.89	26.50	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	257.78	42.25	4.49	3.67	4.69	31.43	1.02	1.63	1.63
hippocampus, adult, donor10258	10374-105G5	160.84	27.89	2.49	1.49	4.98	14.94	1.00	1.99	1.00
hippocampus, newborn, donor10223	10363-105F3	95.87	25.03	2.11	3.88	3.52	19.03	0.70	0.35	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	67.75	4.88	0.00	0.00	1.22	9.16	0.00	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	42.81	2.55	0.20	0.00	1.18	5.69	0.20	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	53.83	2.54	1.52	0.00	1.02	6.86	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	48.49	0.56	1.13	0.00	0.00	3.38	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	33.31	1.55	0.00	0.00	0.26	4.91	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	51.25	1.52	0.38	0.00	0.76	4.18	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	77.37	2.92	0.58	0.00	0.88	7.88	0.00	0.88	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	56.01	3.23	0.86	0.00	1.08	5.60	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	75.49	2.50	1.67	0.00	1.67	7.09	0.00	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	58.72	4.97	1.18	0.00	1.89	10.18	0.47	0.71	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	56.57	5.63	0.64	0.16	1.13	7.23	0.00	0.00	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	68.68	2.02	0.00	0.00	1.35	5.39	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	47.26	0.94	0.47	0.47	0.47	4.54	0.00	0.16	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	41.27	1.97	0.00	0.49	0.98	7.86	0.00	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	56.73	3.49	0.00	0.00	0.00	6.11	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	39.71	1.72	0.95	0.00	0.19	2.67	0.19	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	34.45	0.87	0.44	0.00	0.00	4.36	0.00	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	38.98	1.00	0.50	0.50	0.50	2.50	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	29.01	1.51	0.38	0.00	0.75	4.71	0.00	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	39.56	1.82	0.45	0.45	0.91	6.37	0.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.84	1.57	0.00	0.00	0.00	4.70	0.00	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	35.11	4.90	0.49	0.16	0.65	7.35	0.16	0.33	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	35.42	5.23	0.00	0.00	0.29	5.81	0.00	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	47.53	5.98	1.20	0.00	0.60	8.67	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	45.08	2.96	0.00	0.00	0.55	5.54	0.00	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	41.65	4.56	0.00	0.00	0.86	4.85	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	59.21	2.86	0.82	0.00	0.82	6.94	0.00	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	38.73	0.70	0.35	0.00	1.06	4.93	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	38.33	1.90	0.32	0.00	0.32	1.90	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	48.42	1.51	0.61	0.30	0.61	4.24	0.00	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	35.68	2.07	0.00	0.00	0.52	5.69	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	37.86	1.99	1.33	0.00	0.66	6.64	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	52.59	4.10	0.77	0.00	0.77	5.90	0.00	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	39.63	4.09	0.00	0.26	1.53	5.88	0.00	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	50.73	6.06	0.00	0.76	0.76	3.03	0.00	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	36.97	3.70	0.67	0.00	1.34	5.04	0.00	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	44.92	3.38	0.24	0.00	0.00	5.31	0.48	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	42.34	4.46	0.00	0.45	0.89	9.36	0.00	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	47.32	1.95	0.00	0.00	0.98	4.88	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	42.48	2.44	0.31	0.00	0.31	3.06	0.31	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	81.33	0.00	3.25	3.25	0.00	19.52	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	43.68	0.66	0.66	0.00	0.66	2.98	0.00	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	45.97	3.28	0.55	0.00	0.55	6.57	0.00	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	44.15	2.53	0.72	0.00	0.36	6.15	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	50.89	2.85	1.07	0.00	0.00	5.69	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	28.64	0.00	0.00	0.00	3.58	2.39	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	49.02	4.33	1.08	0.14	1.63	7.04	0.00	0.00	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	39.60	2.96	1.08	0.27	0.81	4.85	0.27	0.27	0.00
immature langerhans cells, donor1	11904-125F5	39.95	9.20	0.24	0.00	0.48	1.70	0.24	0.00	0.48
immature langerhans cells, donor2	11905-125F6	35.65	3.96	0.00	0.00	0.00	0.79	0.00	0.00	1.58
insula, adult, pool1	10039-101F3	224.94	65.01	4.45	7.95	6.53	46.09	2.56	1.32	0.85
keratoacanthoma cell line:HKA-1	10791-110H8	26.34	2.28	0.00	0.00	0.00	0.33	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	70.29	4.01	0.80	0.00	0.00	4.01	0.10	0.10	0.10
kidney, fetal, pool1	10045-101F9	63.03	5.23	0.71	0.42	0.42	6.22	0.42	0.42	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	59.65	3.98	0.99	0.57	0.43	6.11	0.14	0.14	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	31.10	1.94	0.55	0.14	0.41	4.42	0.00	0.00	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	29.18	1.47	0.37	0.00	0.18	2.57	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	38.68	2.72	0.00	0.00	0.54	3.81	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	43.49	1.01	0.51	0.00	1.52	3.03	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	59.92	4.65	1.09	0.27	0.55	8.48	0.00	0.55	0.27
leiomyoma cell line:10964C	10569-108B2	22.99	1.80	0.72	0.00	0.36	3.23	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	14.67	4.35	0.00	0.54	0.00	5.43	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	19.43	1.46	0.24	0.00	0.97	4.86	0.00	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	0.00	0.00	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	33.46	1.05	1.05	1.05	0.00	1.05	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	104.01	18.54	1.06	0.94	2.13	18.18	0.35	0.00	0.83
liposarcoma cell line:KMLS-1	10782-110G8	18.59	2.50	0.16	0.16	0.31	2.19	0.00	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	50.20	5.36	0.12	0.24	0.49	3.90	0.12	0.12	0.00
liver, adult, pool1	10018-101C9	40.03	2.59	0.81	0.32	0.00	1.94	0.00	0.16	0.00
liver, fetal, pool1	10086-102B5	20.70	2.82	0.00	0.00	0.00	1.88	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	148.16	19.25	2.77	1.17	5.40	23.33	0.29	1.31	0.44
locus coeruleus, adult, donor10252	10165-103B3	186.95	20.30	3.69	2.95	6.64	25.65	0.55	2.03	1.11
locus coeruleus, adult, donor10258	10375-105G6	102.13	9.59	1.69	1.41	3.10	11.85	0.28	1.69	0.00
locus coeruleus, newborn, donor10223	10362-105F2	79.92	7.57	0.42	1.26	2.52	18.93	0.00	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	14.25	1.94	0.00	0.00	0.28	3.18	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	54.46	3.45	2.07	0.00	0.00	4.83	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	87.79	4.61	1.85	0.13	0.79	3.69	0.13	0.13	0.13
lung, adult, pool1	10019-101D1	56.94	2.24	0.47	0.00	0.24	2.48	0.12	0.00	0.00
lung, fetal, donor1	10068-101I5	56.51	6.28	0.29	0.57	0.29	4.00	0.00	0.29	0.57
lung, right lower lobe, adult, donor1	10075-102A3	45.82	3.67	0.46	0.00	0.46	3.21	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	34.08	1.42	0.00	0.47	0.00	3.31	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	41.42	2.41	0.44	0.00	0.44	1.10	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	31.24	3.02	0.75	0.30	1.06	5.13	0.45	0.30	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	75.61	9.34	0.00	0.85	0.85	8.49	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	55.94	4.88	2.22	0.00	0.00	2.66	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	54.58	3.11	0.62	0.21	0.42	1.66	0.00	0.42	0.00
mature adipocyte, donor3	12233-129G1	45.28	4.50	0.24	0.24	0.00	0.71	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	39.22	2.90	0.26	0.00	0.00	1.05	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	69.10	6.67	0.95	0.24	0.24	13.10	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	138.75	39.48	1.13	1.13	0.00	24.82	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	230.07	43.22	3.68	2.76	7.17	31.63	1.29	1.47	2.39
medial frontal gyrus, adult, donor10258	10368-105F8	116.59	21.92	2.22	0.95	5.72	15.88	0.64	0.95	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	92.12	29.43	2.13	4.26	12.37	43.08	0.00	0.00	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	143.61	34.26	2.19	2.53	6.92	31.56	0.51	0.68	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	236.21	36.29	4.46	2.55	5.09	34.59	1.06	1.06	1.70
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	75.12	21.19	0.00	0.00	7.71	7.71	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	401.90	114.83	0.00	0.00	0.00	215.30	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	93.32	43.07	1.44	4.31	5.03	17.23	0.36	1.79	3.59
medulla oblongata - adult, donor10196	10174-103C3	93.45	6.49	0.65	0.00	3.24	13.63	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	168.89	16.41	2.94	1.55	3.56	19.97	0.31	0.46	1.08
medulla oblongata, adult, pool1	10038-101F2	178.68	22.28	4.49	2.04	4.24	27.43	0.90	1.39	0.98
medulla oblongata, newborn, donor10223	10361-105F1	112.49	12.85	1.04	2.08	2.78	14.23	0.00	0.35	1.04
medulloblastoma cell line:D283 Med	10838-111E1	83.92	4.21	0.44	0.44	0.00	5.98	0.00	0.00	0.44
medulloblastoma cell line:ONS-76	10759-110E3	37.29	3.18	0.24	0.73	0.37	3.67	0.24	0.00	0.37
melanoma cell line:COLO 679	10514-107E1	24.29	4.46	0.00	0.72	0.29	3.31	0.14	0.00	0.14
melanoma cell line:G-361	10465-106H6	29.05	4.61	1.36	0.54	0.00	6.79	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	22.97	1.45	0.00	0.18	0.18	1.81	0.00	0.00	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	118.08	18.50	1.76	0.00	4.41	22.91	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	91.51	9.59	2.07	0.00	2.59	15.03	0.00	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	19.64	3.53	0.00	0.15	0.15	3.68	0.15	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	17.81	1.45	0.18	0.18	0.18	2.91	0.00	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	13.25	1.66	0.00	0.00	0.83	3.31	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.42	2.39	0.28	0.28	0.42	2.53	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	21.38	3.27	0.00	1.35	0.77	2.70	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.05	2.08	0.00	0.00	0.00	2.78	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.16	1.72	0.00	0.00	0.00	2.23	0.00	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	18.86	2.76	0.12	0.12	0.35	2.65	0.12	0.00	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	18.44	3.18	0.13	0.27	0.53	3.71	0.00	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	15.93	2.30	0.14	0.27	0.68	4.05	0.27	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	17.78	2.56	0.14	0.14	0.43	4.27	0.00	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.11	1.98	0.33	0.00	0.00	0.99	0.00	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	20.89	2.35	0.14	0.28	0.42	1.94	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	25.13	1.40	0.00	0.00	1.75	4.89	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.27	2.04	0.00	0.61	0.20	2.86	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	17.61	2.52	0.00	0.72	1.08	2.16	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.28	1.55	0.21	0.10	0.21	2.17	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.49	2.51	0.23	0.00	0.68	1.82	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	16.36	4.62	0.00	0.42	1.26	6.29	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	15.69	1.79	0.00	0.15	0.45	4.03	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	15.14	2.28	0.09	0.09	0.35	2.98	0.09	0.00	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.83	2.21	0.00	0.00	0.37	1.10	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.60	0.86	0.29	0.00	0.00	1.72	0.00	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	29.47	2.11	0.00	0.00	0.00	8.42	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.53	2.28	0.00	0.00	0.00	1.83	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.63	1.53	0.51	0.26	0.00	1.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	17.80	1.31	0.26	0.00	0.00	1.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.49	2.16	0.00	0.31	0.00	1.23	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.95	3.06	0.24	0.00	0.47	1.65	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	17.94	2.37	0.34	0.00	0.00	1.02	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	17.29	5.11	0.39	0.00	0.39	1.57	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.68	2.78	0.00	0.00	0.46	0.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	22.50	3.17	0.00	0.00	0.00	2.88	0.00	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	20.97	1.78	0.45	0.00	0.00	1.56	0.00	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.06	3.36	0.24	0.00	0.24	2.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.07	3.67	0.00	0.73	0.00	3.67	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	18.13	2.35	0.00	0.00	0.00	0.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	17.19	2.46	0.00	0.00	0.41	3.28	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	19.76	3.44	0.43	0.43	0.43	1.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	24.03	1.30	0.00	0.00	0.00	2.92	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	7.27	0.00	0.00	1.45	2.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	17.59	1.60	0.00	0.00	0.00	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	0.00	0.00	0.00	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.60	1.17	0.00	0.00	0.39	1.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	2.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	14.90	1.99	0.00	0.00	0.00	0.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	9.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.79	1.19	0.00	0.00	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.63	1.27	0.00	0.00	0.00	0.63	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.80	1.38	0.00	0.00	0.69	0.69	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	0.00	2.15	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	9.78	0.00	0.00	0.00	0.00	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.92	0.00	0.00	0.00	0.00	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.92	0.59	0.00	0.00	0.59	1.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	16.83	0.62	0.00	0.00	0.00	0.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	0.00	0.00	0.00	0.00	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	1.18	0.00	0.00	0.00	3.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	0.00	0.00	0.00	0.00	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.96	4.13	0.00	0.00	1.38	1.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	21.77	2.47	0.00	0.99	0.00	1.48	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	1.12	0.00	0.00	1.12	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	22.26	0.00	0.00	0.00	0.00	1.91	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.40	0.40	0.00	0.00	0.00	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	0.00	4.36	0.00	0.00	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	25.34	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.17	0.61	0.61	0.00	0.61	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	8.24	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.22	0.40	0.00	0.00	0.79	1.98	0.00	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	24.34	0.97	0.65	0.00	0.65	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	29.40	4.64	0.77	0.00	0.00	5.42	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	45.59	2.13	0.71	0.00	0.47	4.02	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	19.92	3.71	0.93	0.00	2.32	8.34	0.23	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	10.69	4.73	0.00	0.00	0.41	3.70	0.00	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	25.19	4.54	0.23	0.23	0.68	4.09	0.00	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	29.09	2.44	0.73	0.24	0.00	3.91	0.00	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	21.04	2.21	0.00	0.00	0.00	1.55	0.22	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	23.13	3.94	0.26	0.00	0.79	3.42	0.26	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	29.45	5.62	0.51	0.17	0.68	3.74	0.17	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	29.32	5.81	0.25	0.25	1.52	2.78	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	23.40	2.69	0.21	0.00	0.41	4.35	0.21	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	14.91	1.99	0.00	0.17	0.99	1.99	0.17	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	18.10	5.79	0.00	0.00	1.99	4.52	0.36	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	37.75	4.44	0.00	0.17	0.51	3.93	0.17	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	36.90	2.80	0.00	0.00	0.25	8.40	0.00	0.25	0.25
mesothelioma cell line:No36	10857-111G2	29.68	3.26	0.33	0.33	0.98	4.57	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	22.49	3.79	0.54	0.27	0.00	0.81	0.00	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	20.15	10.17	0.00	0.00	0.00	4.61	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	23.32	8.91	0.61	0.00	0.24	3.05	0.12	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	32.31	8.79	0.00	0.00	0.18	3.05	0.18	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	41.46	2.94	0.98	0.00	0.33	3.59	0.00	0.00	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	18.86	1.70	0.00	0.21	0.21	4.03	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	77.63	7.14	1.15	0.00	0.46	3.69	0.46	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	15.22	2.47	0.00	0.00	0.00	1.33	0.38	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	95.54	2.22	0.92	0.00	0.37	7.76	0.00	0.55	0.74
myeloma cell line:PCM6	10474-106I6	46.06	4.74	0.40	0.00	0.79	6.52	0.00	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	33.48	4.57	0.00	0.51	0.00	4.57	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	32.17	2.55	0.20	0.20	0.20	2.75	0.20	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	20.50	1.56	0.11	0.11	0.00	2.01	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	22.14	1.99	0.37	0.07	0.15	2.06	0.07	0.15	0.15
nasal epithelial cells, donor2	12227-129F4	41.95	1.10	0.55	0.00	0.00	2.21	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	135.74	17.48	1.15	0.23	4.14	31.52	0.00	0.00	0.46
neuroblastoma cell line:NB-1	10539-107G8	80.07	7.48	1.12	1.12	1.12	16.09	0.37	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	62.00	8.01	0.63	0.42	0.63	4.43	0.21	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	101.37	8.76	1.12	0.19	0.93	10.06	0.19	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	56.46	8.78	0.71	0.00	0.24	5.46	0.00	0.71	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	43.55	3.80	1.11	0.63	0.32	3.96	0.16	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	63.20	4.23	0.60	0.20	0.40	7.85	0.00	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	103.63	10.81	0.00	0.00	0.00	7.63	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	27.15	2.66	0.00	0.00	0.53	1.60	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	1814.73	119.00	0.00	0.00	0.00	14.87	0.00	0.00	29.75
neutrophil PMN, donor2	12137-128E4	159.37	0.00	0.00	0.00	13.28	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	104.18	9.47	0.00	0.00	0.00	0.00	0.00	0.00	18.94
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	131.24	10.32	0.51	0.34	1.18	8.29	0.68	0.34	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	48.03	4.80	0.00	0.00	3.20	4.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	23.40	2.89	0.00	0.00	0.32	2.56	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	24.44	3.15	0.26	0.26	0.26	3.94	0.53	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	196.95	54.84	3.94	2.53	4.69	33.09	1.12	1.12	0.94
occipital cortex - adult, donor10196	10172-103C1	162.77	26.78	0.00	2.06	8.24	20.60	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	271.85	40.52	3.76	1.88	6.17	30.59	1.07	0.54	1.07
occipital cortex, newborn, donor10223	10355-105E4	107.73	49.86	4.73	7.28	3.64	31.30	0.36	1.09	2.18
occipital lobe, adult, donor1	10076-102A4	170.03	35.16	1.05	3.67	3.67	27.81	0.26	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	177.22	34.76	3.00	0.43	3.00	59.64	1.29	0.43	0.00
occipital pole, adult, pool1	10036-101E9	157.45	32.64	3.63	3.07	2.37	23.97	0.39	0.55	0.47
olfactory region, adult	10195-103E6	162.97	31.71	1.72	2.10	4.20	34.96	0.96	0.57	0.57
optic nerve, donor1	10277-104E7	116.06	8.00	0.00	0.00	2.00	14.01	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	27.91	3.87	0.11	0.46	0.57	2.85	0.11	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	42.59	2.06	0.14	0.00	0.14	5.08	0.27	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	32.34	3.56	0.34	0.34	0.51	2.71	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	33.84	3.93	0.23	0.12	0.35	2.19	0.23	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	23.22	4.12	0.29	0.00	0.29	1.47	0.29	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	124.27	7.47	0.93	0.93	0.00	9.34	0.00	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	62.13	7.63	0.42	1.27	0.64	4.24	0.00	0.00	1.06
ovary, adult, pool1	10020-101D2	75.03	3.41	0.79	0.44	0.35	4.28	0.17	0.00	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	27.31	2.75	0.00	0.18	0.18	4.22	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	67.73	1.88	0.94	0.00	0.94	9.41	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	37.74	2.52	0.56	0.00	0.00	3.63	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	37.65	4.43	0.51	0.00	0.34	4.94	0.17	0.00	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	31.63	2.65	0.00	0.00	0.17	2.32	0.00	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	190.27	48.14	3.84	5.49	6.22	36.97	1.56	0.92	0.55
parietal cortex, adult, donor10258	10373-105G4	118.91	28.63	0.00	3.67	4.40	12.48	1.47	0.00	1.47
parietal lobe - adult, donor10196	10171-103B9	168.35	29.15	0.94	2.82	4.70	31.98	0.94	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	206.65	44.18	3.99	3.14	6.56	32.78	1.71	1.14	1.14
parietal lobe, adult, pool1	10034-101E7	200.12	48.47	2.56	4.32	5.82	35.25	1.06	0.70	0.35
parietal lobe, fetal, donor1	10072-101I9	148.38	30.06	0.97	0.97	4.85	42.67	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	100.57	38.51	2.99	9.35	9.72	29.53	0.37	0.75	2.24
parotid gland, adult	10199-103F1	57.35	3.08	0.62	0.00	0.62	1.85	0.00	0.00	0.00
penis, adult	10200-103F2	76.81	4.30	1.61	0.54	1.61	5.91	0.00	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	95.01	4.09	1.67	0.00	0.93	6.51	0.00	0.00	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	35.26	1.46	0.15	0.00	0.15	1.75	0.15	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	85.14	7.74	1.94	0.65	0.65	10.32	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	105.41	12.44	2.96	1.18	1.18	10.66	0.00	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	90.93	7.52	1.25	0.00	0.63	4.39	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	59.70	1.01	1.01	0.00	1.01	2.02	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	94.33	2.61	0.00	0.00	1.04	5.21	0.00	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	43.41	1.70	0.00	0.00	0.00	2.55	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	42.03	3.44	0.86	0.00	0.54	2.04	0.00	0.22	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	41.98	2.12	0.26	0.26	0.26	3.18	0.13	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	34.40	3.58	0.93	0.16	0.16	1.87	0.16	0.16	0.00
pons, adult, pool1	10033-101E6	177.30	26.77	5.16	2.24	6.63	40.45	0.34	0.86	0.60
postcentral gyrus, adult, pool1	10032-101E5	182.63	44.11	2.09	3.66	4.62	26.94	1.31	0.61	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	792.64	46.01	2.09	0.00	4.18	18.82	0.00	2.09	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	88.13	0.00	5.51	0.00	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	40.79	4.66	0.29	0.00	0.44	3.06	0.00	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	52.27	2.54	0.54	0.36	0.73	4.54	0.18	0.00	0.18
prostate, adult, pool1	10022-101D4	72.37	4.35	0.91	0.18	0.36	3.90	0.09	0.45	0.18
putamen, adult, donor10196	10176-103C5	207.03	47.21	4.96	1.89	5.19	33.76	1.18	0.71	0.47
putamen, adult, donor10252	10152-102I8	241.17	54.90	1.96	3.92	0.00	9.80	3.92	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	67.75	20.76	0.00	1.09	3.28	9.84	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	166.95	31.41	3.38	0.97	2.66	17.88	0.24	0.72	1.21
putamen, newborn, donor10223	10365-105F5	46.48	9.75	0.00	2.25	4.50	15.74	0.00	0.00	3.00
rectal cancer cell line:TT1TKB	10469-106I1	32.58	2.91	0.29	0.00	0.29	2.33	0.00	0.00	0.87
rectum, fetal, donor1	10067-101I4	70.94	4.17	1.39	0.00	1.39	13.91	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	9.96	1.06	0.00	0.42	0.00	2.97	0.00	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	15.74	0.00	0.41	0.00	0.00	2.49	0.00	0.41	0.41
retina, adult, pool1	10030-101E3	113.51	8.55	1.79	0.80	1.79	9.44	0.20	0.30	0.30
retinoblastoma cell line:Y79	10475-106I7	113.53	10.39	2.86	0.00	0.52	15.85	0.26	0.52	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	48.93	3.69	0.37	0.25	0.12	6.39	0.00	0.00	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	144.82	23.06	3.09	1.97	2.25	15.47	0.00	0.28	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	39.41	3.79	0.00	0.00	0.00	1.52	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	30.43	2.75	0.16	0.00	0.32	3.08	0.00	0.16	0.16
salivary acinar cells, donor2	11772-123I8	33.73	2.75	0.00	0.14	0.28	1.51	0.14	0.00	0.14
salivary acinar cells, donor3	11773-123I9	48.99	3.97	0.00	0.00	0.00	1.32	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	43.47	7.44	0.00	0.00	0.00	2.29	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	34.40	1.10	0.00	0.00	0.08	3.20	0.00	0.25	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	34.09	1.53	0.24	0.00	0.12	3.41	0.12	0.12	0.00
seminal vesicle, adult	10201-103F3	64.55	11.11	0.53	0.00	0.00	4.76	0.00	2.12	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	26.24	3.40	0.24	0.49	0.73	3.16	0.49	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	25.67	4.28	0.50	0.00	0.50	1.01	0.00	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	28.10	3.01	0.00	0.00	0.00	5.02	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	51.04	11.01	0.67	0.40	0.81	3.90	0.13	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	35.26	3.87	0.99	0.11	0.11	4.09	0.11	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	21.68	3.61	0.13	0.00	0.26	1.68	0.13	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	139.74	15.61	0.71	1.42	4.26	12.06	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	99.43	8.64	1.56	0.72	1.32	5.40	0.36	0.60	0.12
skeletal muscle, fetal, donor1	10066-101I3	40.20	7.04	0.00	0.00	1.01	3.02	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	67.54	4.42	0.00	0.63	1.89	10.10	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	45.03	3.00	1.33	0.00	1.00	3.00	0.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	39.72	4.41	1.26	0.00	0.95	4.73	0.00	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	196.60	19.85	1.73	0.58	1.54	23.32	0.39	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	60.49	5.77	0.49	0.33	0.99	7.42	0.16	0.16	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	115.17	2.57	0.97	0.48	1.61	9.49	0.32	0.32	8.36
small cell lung carcinoma cell line:WA-hT	10562-108A4	95.67	15.69	0.22	0.00	1.74	9.59	0.22	0.22	0.00
small intestine, adult, pool1	10024-101D6	61.04	4.66	0.72	0.12	0.12	3.46	0.12	0.12	0.00
small intestine, fetal, donor1	10064-101I1	42.01	1.97	0.49	0.00	0.49	3.93	0.00	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	45.14	5.13	1.54	0.00	1.03	5.13	0.00	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	75.73	4.39	0.00	0.00	0.78	3.88	0.00	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	82.28	5.90	1.07	0.27	1.07	4.29	0.27	0.54	0.54
spinal cord - adult, donor10196	10181-103D1	105.30	11.24	1.61	1.38	5.51	15.14	0.46	0.69	0.69
spinal cord, adult, donor10252	10159-103A6	114.34	14.19	1.58	0.00	0.00	11.83	0.00	1.18	0.39
spinal cord, adult, donor10258	10369-105F9	92.70	3.46	1.38	0.00	2.77	13.14	0.00	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	114.04	10.37	0.00	0.00	7.32	20.73	0.61	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	90.46	5.97	1.38	2.30	3.67	16.07	0.00	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	21.21	4.48	0.30	0.45	0.15	1.64	0.15	0.00	0.00
spleen, adult, pool1	10025-101D7	69.16	2.31	0.88	0.00	0.11	3.63	0.22	0.22	0.22
spleen, fetal, pool1	10044-101F8	55.46	3.65	0.72	0.24	0.00	5.09	0.08	0.16	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	19.25	3.31	0.52	0.31	0.10	3.00	0.10	0.10	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	29.62	2.85	0.57	0.00	0.19	3.23	0.38	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	44.03	6.29	0.00	0.00	1.05	3.84	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	23.46	1.95	0.39	0.39	0.39	3.52	0.39	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	37.71	2.59	0.23	0.00	0.11	3.38	0.23	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	55.92	6.78	1.27	0.00	0.85	3.39	0.00	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	45.69	4.23	0.85	0.00	0.42	8.46	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	45.92	3.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	73.49	3.99	0.00	0.00	1.14	3.99	0.57	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	124.00	12.25	2.49	1.25	2.08	10.18	0.21	0.00	1.45
substantia nigra, adult, donor10258	10371-105G2	158.28	13.97	1.55	1.55	8.79	12.41	0.00	1.03	1.55
substantia nigra, newborn, donor10223	10358-105E7	83.38	7.77	1.41	2.12	3.53	12.01	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	44.48	11.69	1.60	0.00	0.69	5.04	0.69	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	168.44	41.62	3.39	3.65	2.97	29.08	1.02	0.68	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	199.43	44.87	4.27	0.71	3.56	23.50	1.42	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	206.58	43.07	5.27	0.88	3.52	36.04	0.44	0.00	0.88
tenocyte, donor1	11763-123H8	33.16	3.49	0.00	0.00	0.00	2.44	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	33.57	1.91	1.53	1.53	0.00	1.14	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	22.24	2.97	0.00	0.00	0.74	3.71	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	25.66	2.38	0.00	0.17	0.51	5.10	0.17	0.00	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	27.75	2.31	0.31	0.00	0.15	2.77	0.31	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	44.48	1.70	0.31	0.00	0.31	2.48	0.15	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	35.80	3.68	0.76	0.25	0.00	3.05	0.13	0.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	47.27	2.65	0.38	0.00	0.38	2.27	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	24.87	2.73	0.00	0.00	0.65	2.84	0.33	0.00	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	33.55	1.95	0.00	0.33	1.30	1.63	0.00	0.33	0.00
testis, adult, pool1	10026-101D8	69.79	3.87	1.07	0.32	0.64	7.52	0.00	0.32	0.54
testis, adult, pool2	10096-102C6	91.57	2.26	2.71	1.35	1.80	18.04	0.00	0.90	1.80
thalamus - adult, donor10196	10168-103B6	152.35	13.25	2.21	2.21	4.42	18.77	0.00	2.21	1.10
thalamus, adult, donor10252	10154-103A1	210.20	20.79	3.75	1.09	2.19	19.54	0.31	0.78	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	115.47	16.94	0.00	1.54	15.40	9.24	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	92.39	13.18	1.65	1.98	1.48	8.23	0.33	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	54.08	9.21	1.15	2.88	6.33	23.01	0.00	1.15	1.15
throat, adult	10209-103G2	80.39	6.24	1.00	0.25	1.25	6.49	0.25	0.00	0.00
throat, fetal, donor1	10061-101H7	66.12	9.75	0.00	1.22	0.30	6.09	0.00	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	47.89	10.93	0.60	0.20	0.40	2.78	0.40	0.60	0.40
thymus, adult, pool1	10027-101D9	50.11	5.17	0.40	0.30	0.10	4.87	0.10	0.10	0.10
thymus, fetal, pool1	10043-101F7	46.03	3.12	0.52	0.73	0.00	4.26	0.10	0.10	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	37.10	3.99	0.93	0.13	0.00	4.12	0.27	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	51.41	5.45	0.28	0.42	0.42	5.31	0.00	0.00	0.28
thyroid, adult, pool1	10028-101E1	118.79	11.85	1.21	0.65	1.40	8.12	0.19	0.56	0.47
thyroid, fetal, donor1	10060-101H6	73.30	6.86	0.53	0.26	0.26	5.27	0.26	0.79	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	21.56	0.00	0.00	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	62.56	4.88	0.70	0.23	1.40	4.88	0.23	0.00	0.00
tongue, fetal, donor1	10059-101H5	74.48	5.91	0.79	0.39	1.58	9.85	0.39	0.00	0.00
tonsil, adult, pool1	10047-101G2	57.90	4.31	0.50	0.40	0.40	2.91	0.00	0.10	0.00
trachea, adult, pool1	10029-101E2	63.97	4.09	0.57	0.08	0.08	3.84	0.08	0.16	0.00
trachea, fetal, donor1	10058-101H4	60.01	3.85	0.77	0.00	1.54	6.54	0.00	0.38	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	20.19	4.61	0.00	0.35	0.71	4.25	0.00	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	31.61	2.74	0.20	0.10	0.20	3.24	0.00	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	40.43	2.04	0.94	0.16	0.31	6.74	0.00	0.00	0.16
tridermal teratoma cell line:HGRT	10694-109G1	62.78	9.51	0.00	0.00	1.90	7.61	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	27.17	3.72	0.68	0.17	0.08	3.30	0.08	0.08	0.17
umbilical cord, fetal, donor1	10057-101H3	35.47	0.00	0.00	0.00	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	52.55	3.75	0.85	0.68	1.02	4.10	0.00	0.17	0.51
uterus, fetal, donor1	10055-101H1	54.78	6.14	0.00	0.00	1.02	8.19	0.00	1.02	0.00
vagina, adult	10204-103F6	75.61	3.23	0.65	0.00	0.65	3.23	0.00	0.65	0.00
vein, adult	10191-103E2	64.88	2.19	0.66	0.22	0.44	7.23	0.00	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	24.83	3.47	0.00	1.07	1.34	6.14	0.00	0.00	0.00